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ABSTRACT 
Mycobacterium tuberculosis is the etiological agent for tuberculosis, an infectious disease 
which is one of the leading causes of morbidity and mortality in developing countries. The 
emergence of drug resistant tuberculosis has negatively impacted the efficacy of current 
treatment regimens and threatens to undermine tuberculosis control programs worldwide. 
Rifampicin forms the backbone of the World Health Organization’s recommended treatment 
regimen for the treatment of drug susceptible tuberculosis. Resistance to rifampicin is caused 
by mutations in the 81 bp core region of the rpoB gene which encodes the β subunit of RNA 
polymerase. Numerous studies have shown that mutations at codons 531 and 526 are the most 
frequent in clinical isolates, yet little is known concerning the mechanistic effect of these 
mutations on the fidelity of RNA polymerase. In the present study, we aimed to determine the 
influence of rpoB mutations on the gene expression profile of M. tuberculosis cultured in 
vitro. To accomplish this, rifampicin resistant clinical isolates and spontaneous mutants 
(selected in vitro from H37Rv and a drug-sensitive clinical strain) harbouring rpoB H526Y 
and S531L mutations were subjected to whole genome sequencing and genome-wide 
transcriptional profiling. 
When comparing the transcription profile of H37Rv to the in vitro rpoB mutants, a large 
proportion of the differentially expressed genes were found to encode for proteins involved in 
intermediary metabolism and respiration; and cell wall and cell processes. The majority of 
these differentially expressed genes were downregulated. Prominent differential expression in 
the same functional categories was also evident when comparing the clinical isolates with 
these mutations; however, a greater number of genes were differentially expressed in this 
case. Furthermore, expression of genes that are part of the WhiB7 regulon were found to be 
upregulated in the rpoB526 mutants, and downregulated in the rpoB531 mutants. These 
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findings indicate that both the position of the rpoB mutation, as well as the genetic 
background of the strain, play an important role in the gene expression profile of rpoB 
mutants. Surprisingly, transcriptional profiling of cultures that were exposed to the critical 
concentration of rifampicin for 24 hours did not exhibit significant differential gene 
expression. Whole genome sequencing, followed by bioinformatic analysis, revealed that the 
in vitro mutants harbour synonymous and non-synonymous single nucleotide polymorphisms 
in addition to the respective rpoB mutations. This suggests that the mycobacterial genome is 
constantly evolving, challenging previous assumptions of relatively static mycobacterial 
genomes. 
The findings from this research have provided novel insight into understanding the influence 
of resistance-conferring mutations on the biology of M. tuberculosis and have shown that 
further studies are urgently needed to better understand the complex physiology of this 
pathogen. This knowledge will be critical for the success of future drug development 
endeavours. 
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OPSOMMING 
Mycobacterium tuberculosis is die etiologiese agent vir tuberkulose, een van die grootste 
oorsake van morbiditeit en sterftes in ontwikkelende lande. Die verskyning van 
middelweerstandige tuberkulose het 'n negatiewe impak op die effektiwiteit van die huidige 
behandeling van tuberkulose en dreig om tuberkulose beheerprogramme wêreldwyd te 
ondermyn. Weerstandigheid teen rifampisien, een van die eerste-lyn anti-tuberkulose middels, 
word veroorsaak deur mutasies in die 81 bp kerngedeelte van die rpoB geen. Die mees 
algemene mutasies in kliniese isolate word gevind in kodons 531 en 526; alhoewel daar min 
inligting beskikbaar is oor die effek van hierdie mutasies op die funksie van RNS polimerase. 
Die doel van hierdie studie was om die effek van verskillende rpoB mutasies op die geen-
uitdrukkingsprofiel van M. tuberculosis te bepaal. Rifampisien-weerstandige kliniese isolate 
en in vitro mutante (geselekteer vanaf H37Rv en 'n rifampisien-sensitiewe kliniese isolaat) 
met rpoB H526Y en S531L mutasies was vir hierdie doel geselekteer en gebruik om die heel 
genoom volgorde te bepaal en geenuitdrukking te kwantifiseer. 
Vergelyking van die H37Rv transkripsieprofiel met in vitro geselekteerde rpoB mutante het 
getoon dat 'n groot aantal gene wat differensieel uitgedruk is, vir proteïene kodeer wat 
betrokke is in selwand-prosesse en intermediêre metabolisme en respirasie. Die meerderheid 
van hierdie differensieel uitgedrukte gene was afgereguleer. ’n Soortgelyke verskynsel is ook 
waargeneem in kliniese isolate, met die verskil dat 'n groter aantal gene in hierdie geval  
differensieel-uitgedruk was. Gene wat deel vorm van die WhiB7 regulon is opgereguleer in 
die rpoB526 mutante, terwyl dit afgereguleer was in die rpoB531 mutante. Hierdie resultate is 
’n baie sterk aanduiding dat beide die posisie van die rpoB mutasie, asook die genetiese 
agtergrond van die organisme, ’n belangrike rol speel in die uitdrukking van gene in 
rifampisin weerstandige M. tuberculosis. Kulture wat aan die kritiese konsentrasie van 
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rifampisien vir 24 uur blootgestel is, het teenverwagting geen differensiële geen-uitdrukking 
getoon nie. Verder het die heel genoom volgorde bepaling van die in vitro mutante getoon dat 
sinonieme en nie-sinonieme enkel-nukleotied polimorfismes teenwoordig is in die onderskeie 
rpoB mutante. Dit dui daarop dat die mikobakteriële genoom voortdurend verander, moontlik 
nie so stadig as wat voorheen vermoed is nie. 
Die bevindinge van hierdie navorsing bied nuwe insigte om die invloed van mutasies wat 
middel-weerstandigheid veroorsaak op die biologie van M. tuberculosis te verstaan. Dit het 
ook getoon dat verdere studies dringend nodig is om die komplekse fisiologie van hierdie 
patogeen te verstaan. Hierdie kennis sal van kardinale belang wees vir die sukses van 
toekomstige ondernemings om nuwe anti-tuberkulose middels te ontwikkel. 
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1.1 Background  
Mycobacterium tuberculosis, the aetiological agent of tuberculosis (TB), was first described 
by Robert Koch in 1882 (1). Over the past 130 years, this pathogenic bacterial species has 
become one of the largest global health problems and continues to be one of the leading 
causes of morbidity and mortality in low income countries. TB was the cause of 
approximately 1.4 million deaths in 2011 and the emergence of multidrug-resistant (MDR) 
and extensively drug-resistant (XDR) TB poses a major threat to TB control programs 
worldwide (2). This is especially true for countries such as South Africa where more than 
60% of the total TB budget is used to control drug resistant TB (3). With a population of over 
50 million, the prevalence of TB in South Africa was estimated to be more than 760/100,000 
in 2011 (2). According to data from the National Institute for Communicable Diseases, the 
frequency of MDR-TB among new cases was 7.8% in the same year (4). MDR-TB is defined 
as M. tuberculosis which has gained resistance to rifampicin (RIF) and isoniazid, two of the 
most powerful drugs used to treat TB. Treatment of MDR-TB requires the use of highly toxic 
drugs and has poor outcomes, with less than 50% of patients being treated successfully (2). 
 
Drug resistance in M. tuberculosis primarily arises as a result of chromosomal mutations in 
genes which encode drug targets or activators. Resistance to RIF is associated with mutations 
in the RIF resistance-determining region (RRDR) of the rpoB gene which encodes for the β-
subunit of RNA polymerase (RNAp), the primary enzyme responsible for transcription in 
prokaryotes. Numerous amino acid changes in the RRDR have been found to confer RIF-
resistance, however S450L and H445Y mutations are the most frequent in clinical isolates, 
often referred to as S531L and H526Y mutations, respectively, as these are the corresponding 
codon positions in the gene sequence of E. coli. (5).  
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Recent work from our lab has demonstrated that closely related drug resistant M. tuberculosis 
isolates with a mutation in the rpoB gene displays varying levels of RIF resistance. It was 
found that this resistance could largely be reversed with the addition of efflux pump 
inhibitors, suggesting that the activation of efflux pumps is involved (6). A second 
observation from the same study showed that RIF was able to induce tolerance to ofloxacin 
(OFL) in RIF mono-resistant strains, which is one of the most important drugs used to treat 
MDR-TB. Strains with the rpoB526 mutation pre-exposed to RIF showed a limited increase 
in the minimum inhibitory concentration (MIC) of OFL after 7 days. Surprisingly, strains 
with the rpoB531 mutation showed induction of OFL tolerance after only 24 hours. These in 
vitro experiments suggest that certain rpoB gene mutations condition the bacterium to 
becoming more tolerant to other anti-TB drugs when exposed to RIF, which may lead to an 
increased risk of transmission of these strains. This could explain why clinical strains with the 
rpoB531 mutation are more prevalent than those with the rpoB526 mutation, however little is 
known concerning the effect of these mutations on the enzymatic function of RNA 
polymerase. 
 
A study by Bisson et al. demonstrated an upregulation of the phthiocerol dimycocerosate 
biosynthetic pathway upon investigating the proteome and metabolome of RIF-resistant M. 
tuberculosis compared to wild-type (WT) isolates (7). This finding suggests that a single 
mutation in the rpoB gene can have a considerable impact on gene expression in M. 
tuberculosis. In this study, we aim to describe the transcription profile of M. tuberculosis with 
two of the most commonly-found rpoB mutations, S531L and H526Y, as well as the influence 
of these mutations on gene expression during exposure to RIF. Additionally, the genomes of 
the in vitro mutants used in this study will be sequenced to determine whether short 
insertions/deletions (in/dels) or additional single nucleotide polymorphisms (SNPs) were 
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acquired in conjunction with the respective rpoB mutations. This will allow us to confirm 
whether altered gene expression can be attributed to the rpoB mutations alone, or whether 




Mutations in the β-subunit of RNA polymerase lead to diverse changes in the gene expression 
profile of Mycobacterium tuberculosis. 
 
1.3 Aims 
1. Investigate the effect of rpoB526 and rpoB531 mutations on gene expression in 
clinical isolates and in vitro selected mutants of M. tuberculosis. 
2. Determine the transcriptomic response of RIF mono-resistant in vitro selected mutants 
and clinical isolates of M. tuberculosis after 24 hours of RIF exposure. 
3. Determine whether the in vitro selected mutants used in this study harbour additional 
SNPs or short in/dels compared to the respective progenitors. 
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The β and β’ Subunits of Mycobacterial RNA Polymerase: 
Regulatory Hotspot and Drug Target 
 
2.1 Abstract 
This review aims to discuss the bacterial and non-bacterial factors that interact with the β and 
β’ subunits of RNA polymerase at the level of transcription initiation with the view to collate 
the current knowledge regarding the regulation and inhibition of RNA polymerase in 
Mycobacterium tuberculosis. These interactions include sigma factors, small RNAs and 
guanosine tetra- and pentaphosphates, which have all been shown to play a role in regulating 
the pathway from DNA to messenger RNA. Furthermore, numerous antimicrobial agents and 
bacteriophage-encoded transcriptional regulators can bind to RNA polymerase in the same 
region in order to inhibit transcription in prokaryotes. Under certain conditions, M. 
tuberculosis is able to circumvent these inhibitory mechanisms by gaining mutations that 
prevent binding to RNA polymerase. It is evident that certain resistance-conferring mutations 
in M. tuberculosis aid bacterial survival in the face of antibiotic pressure, however little is 
known concerning their mechanistic effect on RNA polymerase or their influence on other 
RNA polymerase-ligand interactions. Review of the literature indicated that certain aspects of 
transcriptional regulation in M. tuberculosis is considerably understudied and that relying on 
studies done in model organisms such as Escherichia coli may not be the ideal way to gain a 
better understanding of mechanisms of regulation in pathogenic mycobacteria. Additional 
studies are urgently needed to fill such knowledge gaps and provide novel insights into the 
link between transcriptional regulation and mycobacterial physiology. 
  




As defined in the central dogma of molecular biology, transcription and translation are the 
fundamental processes involved in the expression of genetic information. DNA-dependant 
RNA polymerase (RNAp) is the primary enzyme responsible for transcription in prokaryotes. 
This large (~400 kDa), multi-subunit enzyme facilitates transcription of genes by binding to 
double-stranded DNA in order to synthesize RNA. Subsequently, messenger RNA (mRNA) is 
translated into proteins, completing the transformation of genetic information from gene to 
functional gene product. As an exception to this rule, ribozymes and several other RNA 
species, such as transfer RNA (tRNA) and ribosomal RNA (rRNA), are functional RNAs that 
are not translated into proteins.  
 
To aid bacterial survival, the types and quantities of proteins present within the cell are altered 
to allow the bacterium to adapt to its environment. Transcriptional regulation is the primary 
process through which gene expression is controlled and consists of numerous networks 
which employ different regulatory mechanisms. Primary examples of these mechanisms 
include classical regulators of transcription such as repressors and activators, which bind to 
promoter regions of DNA in order to regulate the transcription of operons. In most cases, 
repressors prevent binding of RNAp to promoter regions; whereas activators enhance 
transcription by facilitating the link between the α subunits of RNAp and the promoter region. 
Additionally, enhancers are short DNA sequences which bind to DNA without interacting 
with RNAp and are able to activate genes from a distance. This review will discuss 
transcriptional regulators, antibacterial compounds and bacteriophage-encoded proteins that 
interact with the β and β’ subunits of RNAp in M. tuberculosis in order to regulate or inhibit 
enzymatic activity at the level of transcription initiation (Figure 2.1). 
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Figure 2.1 An illustration of the central dogma of molecular biology, the 
primary enzymes involved in each phase and the bacterial and non-bacterial 
factors discussed in this literature review that interact with the β and β’ 
subunits of RNAp. 
2.3 The Structure and Function of RNA Polymerase 
RNAp consists of 5 subunits (α2ββ’ω) and one of 13 sigma (σ) factors (σ
A-M
) in
M. tuberculosis (Figure 2.2) (8). Two identical alpha (α) chains are transcribed from rpoA and 
consist of an N-terminal and C-terminal domain, connected by a flexible linker (9, 10). The 
C-terminal domain interacts with transcription factors and stabilizes the RNAp-promoter 
complex by binding to regions upstream of certain promoters called UP-elements. The beta 
chains, β and β’, are the largest subunits of the enzyme and are encoded by rpoB and rpoC, 
respectively. Together, these subunits are said to resemble crab pincers as they appear to 
clamp the DNA strand during the process of transcription. The β’ and β subunits form the 
DNA-binding channel (DBC), containing the active-centre cleft for ribonucleotide 
polymerization (11). Important characteristics of the β’ subunit include the zipper, which 
separates the RNA-DNA hybrid, and the rudder, which divides the DBC and the smaller 
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secondary channel where ribonucleotides enter and join the growing strand of RNA. The 
dimerization of the omega (ω) subunit, encoded by rpoZ, is the first step in the assembly of 
the subunits which make up the core enzyme, thereafter binding of the dissociable σ factor 
allows the enzyme to recognize and bind to specific promoter regions (12). 
 
 
Figure 2.2 The crystal structure of E. coli σ70 RNAp illustrating 
the six subunits (α2ββ’ωσ) that form the holoenzyme and the 
active site located between the β and β’ subunits (13). 
Illustration generated using Cn3D version 4.3 (14). 
 
 
The transcription cycle consists of three main steps: initiation, elongation and termination. 
During initiation, a single σ factor binds to the RNAp core to form a holoenzyme, which aids 
promoter recognition by decreasing the affinity of RNAp for non-specific DNA. The unbound 
RNAp holoenzyme, referred to as the closed promoter complex (RPc), binds to regions -10 
and -35 of the promoter region and undergoes numerous conformational changes to form the 
transcriptionally active open promoter complex (RPo). Subsequently, promoter DNA interacts 
with the DBC of RNAp, enabling the DNA strand to curve at the -10 region (15). Once 
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loading of the DNA strand has taken place, double-stranded DNA at the transcription start site 
is melted, leading to the formation of a transcription bubble and the initiation of 
ribonucleotide polymerization (Figure 2.3). The σ factor dissociates from the complex once a 
9-10 nucleotide strand of RNA has been synthesized, thereafter the core enzyme continues 




Figure 2.3 An illustration of transcription initiation in prokaryotes: A) The σ factor 
recognizes and binds to regions -10 and -35 of the promoter region; B) DNA is 
loaded into the DBC by curving at the -10 region; C) The σ factor dissociates once a 
9-10 nucleotide strand has been synthesized and elongation of the mRNA continues. 
 
2.4 Bacterial Transcriptional Regulators 
2.4.1 Sigma Factors 
Different σ factors bind to RNAp and alter the affinity of the enzyme for specific promoter 
regions (16). Adaptation of the bacterium to external stress or internal stimuli is made 
possible through binding of specific σ factors, which lead to diverse transcriptional responses. 
Two main families of σ factors have been described in prokaryotes, grouped according to 
their molecular weights: RpoN-like σ54 and RpoS-like σ70, which are 54 kDa and 70 kDa, 
respectively. All 13 σ factors in M. tuberculosis are part of the σ70 family which consists of 
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four conserved regions. Domains 2.3-2.4, 3.0 and 4.2 have been found to bind to promoter 
regions -10, extended -10 and -35, respectively (Figure 2.4).  
 
Figure 2.4 An illustration of the DNA promoter region and domains 1-4 found within σ70. 
 
 
The primary σ factor in M. tuberculosis is σA, which is responsible for transcription of 
housekeeping genes that are involved in essential cellular pathways. When the bacterium 
undergoes stress, the expression of alternative σ factors is induced, which allows them to 
compete with σA for binding to RNAp, thereby directing transcription from different promoter 
regions (Table 2.1). Ten of the σ factors in M. tuberculosis (all except σA, σB and σF) belong 
to the extracytoplasmic function (ECF) subfamily of σ factors which are characterized based 
on their sequence homology. Members of this family have been found to regulate proteins 
with extracytoplasmic functions or proteins involved in adaptation to extracytoplasmic 
stresses such as oxidative stress, heat shock or surface stress (17). Additional mechanisms of 
regulation include anti-σ factors, which bind to σ factors to prevent them from binding to the 
RNAp core, and anti-anti-σ factors are able to inhibit anti-σ factors to counteract this 
mechanism.  
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Table 2.1 Sigma factors found in M. tuberculosis with known external stress and internal 
stimuli that induce their expression. 
Sigma Factor Factors which induce expression References 
σA Human macrophage infection (18) 
σB 
Heat-shock, surface stress, low aeration, oxidative stress, 
stationary phase, nutrient starvation 
(19–21) 
σC Early phase of oxygen depleted dormancy (22) 
σD Nutrient starvation (21) 
σE 
Heat-shock, surface stress, human  macrophage infection, 
nutrient starvation 
(18, 19, 21, 
23) 
σF 
Antibiotic stress, nutrient starvation, oxidative stress,  
cold-shock, anaerobic metabolism, stationary phase 
(21, 24) 
σG Human macrophage infection (18) 
σH Heat-shock, human macrophage infection, oxidative stress (19, 23, 25) 
σI Mild cold-shock, late stationary phase (19, 26) 
σJ 
Late stationary phase, human macrophage infection, 
oxidative stress 
(26–28) 
σK, σL, σM  Unknown - 
 
2.4.2 Guanosine Nucleotides 
Guanosine tetra- and pentaphosphates (ppGpp/pppGpp), collectively referred to as guanosine 
nucleotides in this review, are synthesized by the phosphorylation of GDP and GTP, 
respectively. In E. coli and other Gram-negative prokaryotes, the enzymes RelA and SpoT 
modulate levels of (p)ppGpp in the cell, however only a single  bifunctional enzyme (RelMtb) 
exists in M. tuberculosis, which is responsible for both the synthesis and hydrolysis of 
(p)ppGpp (29, 30). This dual-function enzyme comprises of 738 amino acid residues and two 
catalytic domains, with amino acid fragments 1-394 and 1-181 shown to be responsible for 
(p)ppGpp synthetase and hydrolase activity, respectively (31).  
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Guanosine nucleotides are transcriptional regulators which form part of the stringent response 
in most prokaryotes and accumulate when amino acid availability is low (32, 33). Stringently 
controlled genes are highly-expressed during optimal growth conditions; however their 
transcription is discontinued in nutrient-limited environments in order to conserve cellular 
resources. When the stringent response is triggered by the presence of uncharged tRNA, RelA 
activity is induced, leading to an increase in the level of (p)ppGpp. Guanosine nucleotides, 
together with a protein called DksA, bind directly to RNAp and regulate transcription 
initiation in E. coli (34). Transcription from promoters which control expression of genes 
encoding rRNA, ribosomal proteins and regulators of protein translation are downregulated 
due to the limited supply of amino acids (35). Conversely, transcription from genes that 
encode alternative σ factors and amino acid biosynthesis are induced (36). It has also been 
found that guanosine nucleotides are able to regulate RNAp activity indirectly in E. coli by σ 
factor competition (37). This mechanism prevents RNAp from binding of the σ factor which 
is responsible for expression of housekeeping genes. As a result, alternative σ factors can bind 
to RNAp and drive transcription of regulons which are essential for survival. In both cases, 
SpoT hydrolase activity allows for decreased levels of guanosine nucleotides once ideal 
environmental conditions return, which restores transcription of genes that are needed for 
bacterial replication (Figure 2.5). A study by Dahl and colleagues demonstrated that p/ppGpp 
regulates the expression of 159 genes in M. tuberculosis during starvation (38). A number of 
these genes were found to be linked to persistence and the repression of metabolism which 
allow for an increased chance of survival in adverse conditions.  
 




Figure 2.5 The role of (p)ppGpp in the stringent response in E. coli. The alarmone 
(p)ppGpp, synthesized in abundance as a response to limited amino acids, binds 
directly to bacterial RNAp together with DksA in order to regulate transcription. Once 
suitable environmental conditions return, SpoT hydrolase activity degrades guanosine 
nucleotides, allowing expression of genes that are essential for replication. 
 
Guanosine nucleotides are able to regulate transcription by binding to RNAp at a site near the 
N-terminus of the β’ subunit and the C-terminus of the β subunit (39). It has been found that 
RIF-resistant E. coli mutants, harbouring mutations at codons 331 and 332 in rpoB, exhibit a 
20-fold increase in intracellular sensitivity to guanosine nucleotides (40, 41). However, the 
levels of ppGpp were approximately 10 times lower in these rpoB mutants compared to the 
WT strains, indicating an effect of rpoB mutations on ppGpp metabolism. It would be 
noteworthy to assess whether the same phenomenon is seen in strains of M. tuberculosis 
harbouring rpoB mutations. A homolog for DksA has not been identified in M. tuberculosis, 
however a transcriptional regulator named CarD has been found to share many similarities 
(42). CarD is induced by starvation as well as DNA damage in mycobacteria and is able to 
complement a ∆dksA strain of E. coli (43). However CarD is thought to function in a different 
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mechanism to DksA, as it binds to a different site on RNAp (N terminus of the β subunit). 
Furthermore, expression of CarD is vital for mycobacterial viability under all conditions, 
whereas DksA is not essential when E. coli is growing in a nutrient-rich environment.  
 
The stringent response is one of the factors which contribute towards long term survival of  
M. tuberculosis (38). For this reason, our knowledge of guanosine nucleotides and 
transcriptional regulators which induce the stringent response play an important role in 
understanding persistent TB infections. Numerous studies have contributed to our knowledge 
of the global role of this alarmone in E. coli, however many aspects of (p)ppGpp synthesis 
and function in M. tuberculosis remain to be investigated. 
 
2.4.3 Small RNA 
It has long been known that small RNA (sRNA) plays a major role in posttranscriptional 
modulation, mainly through binding to complementary segments of target mRNA, thereby 
changing the stability of the mRNA and altering translation. However, it has recently been 
discovered that a number of sRNAs are linked to transcriptional regulation in prokaryotes. 6S 
sRNA in E. coli has been found to repress transcription from σ70–dependent promoters by 
binding to RNAp during stationary phase (44, 45). For this reason, 6S RNA is thought to play 
a role in the transcriptional shift from exponential to stationary phase in prokaryotes. 
Furthermore, 6S RNA has been shown to act as a transcription template when binding to 
RNAp to initiate de novo synthesis of RNA molecules (46). However, it is unknown whether 
these transcripts are involved in transcriptional regulation or 6S RNA function. Results from a 
study by Arnvig et al suggests that MTS2823 in M. tuberculosis is functionally homologous 
to 6S RNA as it is able to modulate the downregulation of genes that are involved in 
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exponential growth (47). The mechanism through which this occurs remains unclear, however 
characterisation of MTS2823 may reveal a link between the modulation of transcription by 
sRNA and the downregulation of genes, which is characteristic of persistent M. tuberculosis 
infections (22, 48). 
 
In a study which aimed to identify proteins that bind to sRNA in E. coli, it was revealed that a 
number of different sRNAs bind to the β subunit of RNAp, cleaving and extending the 3’ end 
of the sRNA strands (49). The authors suggested that sRNA binds to the active cleft of RNAp, 
which is able to execute RNA-dependent polymerase activity. As the majority of essential 
cellular processes and machinery remain conserved among prokaryotes, one could propose 
that sRNA plays a similarly important role in mycobacteria, however further studies are 
needed to investigate this. 
 
sRNA can also regulate transcription indirectly, by increasing translation of σ factors which 
bind to RNAp, bringing about a transcriptional response. In E. coli, the rpoS gene encodes for 
σS, which binds to RNAp and drives transcription of certain genes in response to external 
stress stimuli or entry into stationary phase (50, 51). During exponential growth, the 5’ end of 
rpoS mRNA forms a hairpin-loop which obstructs the Shine Delgarno ribosome-biding site, 
thereby preventing initiation of rpoS translation (52). As an increased need for σS arises, DsrA 
sRNA, with the help of the Hfq chaperone, binds to a region of the hairpin-loop, thereby 
exposing the Shine Delgarno ribosome-binding site and enabling translation of rpoS mRNA 
(Figure 2.6) (53). In the absence of DsrA, RprA sRNA has been shown to play a similar role 
in the positive regulation of σS translation, suggesting that multiple sRNAs can interact with 
the same mRNA (54).  
 




Figure 2.6 Regulation of rpoS translation by DsrA sRNA and Hfq in E. coli. 
SD: Shine Delgarno ribosome-binding site. Illustration adapted from Soper 
and Woodson (55). 
 
 
An Hfq homolog has not been identified in M. tuberculosis; however it may be possible that 
sRNA regulates the expression of σ factors in a comparable way. Furthermore, DsrA has been 
shown to play a direct role in transcription, by overcoming H-NS silencing of the gene which 
encodes RcsA, a positive regulator of capsular polysaccharide synthesis in E. coli (56). This 
indicates that a single sRNA can influence the regulation of both transcription and translation 
in diverse ways. As the majority of these regulatory pathways have only been investigated in 
E. coli and other prokaryotes, additional studies in M. tuberculosis are needed to assess the 
influence of sRNA on transcriptional regulation in this species. Recently, a number of sRNAs 
have been identified and characterised in M. tuberculosis, however further investigation will 
be necessary to determine the functional role of these non-coding RNAs in mycobacterial 
gene regulation (57, 58). 
 
2.5 Non-Bacterial Transcriptional Regulators 
Bacteriophages (phages) are viruses which infect and kill bacterial cells. Once inside the 
bacterial host, transcription of early viral genes takes place by means of the host RNAp, the 
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primary enzyme responsible for gene transcription in prokaryotes. Thereafter, host 
transcription is inhibited and viral transcription of middle and late viral genes continue via 
phage-encoded RNAp. One of the ways in which phages inhibit host transcription is though 
phage-encoded proteins which bind to bacterial RNAp. A well-studied example of this 
interaction is that of T7 phage protein, Gp2, which effectively binds to and inhibits RNAp 
activity in E. coli (59–62). The binding of Gp2 to the β’ subunit of RNAp, coded by the rpoC 
gene, has been found to be σ factor dependent, indicating that Gp2 may also play a role in the 
regulation of bacterial transcription (63).  
 
Numerous studies have been done to investigate the mechanism of action of this small (~7 
kDa), yet potent transcriptional inhibitor. Residues R56 and R58, located on the surface of 
Gp2, have been found to be important in binding of Gp2 to the β’ subunit of RNAp (64). A 
multiple sequence alignment of 33 phage proteins that are known homologs of Gp2 revealed a 
high level of conservation at amino acids R56 and R58, indicating the importance of these 
residues in protein function (65). It was also found that substitutions that cause a charge 
reversal at these positions lead to decreased activity in vitro and in vivo, which suggests that 
an electrostatic component may be involved. Once Gp2 is bound to RNAp, a strip of 7 
negatively charged amino acid side chains (E24, E34, D37, E38, E41, E44, E53,) face the 
downstream DBC (Figure 2.7). This is thought to aid inhibition of RNAp by either repelling 
negatively charged DNA or preventing conformational changes needed for stable RPo 
formation (64). 
 
An alternative method used by phages to gain control of the transcription machinery within 
the host is through covalent modification such as ADP-ribosylation. An example of this 
mechanism is the interaction between AsiA, a 10 kDa T4 phage-encoded protein, and RNAp  




Figure 2.7 A. Ribbon structure of Gp2, illustrating negatively-
charged amino acid side chains in red and positively-charged 
amino acid side chains in blue. B. Illustration of the basic 
electrostatic surface distribution on the molecular surface of Gp2. 
Adapted from Cámara et al (64). 
 
in E. coli (66, 67). Firstly, the early viral genes mod and alt encode for ADP-ribosylases 
which modify α subunits of bacterial RNAp. Thereafter, AsiA binds to the modified enzyme 
to induce transcription of middle viral genes (68). Alternate σ factor gp55 is one of the middle 
genes that are transcribed which, in turn, induces transcription of late viral genes (69). At this 
stage, AsiA acts as an anti-σ factor by binding to σ70 and allowing phage-encoded gp55 to 
bind instead (70). This process of transcription from early to late viral genes is dependent on 
AsiA, revealing its role as a temporal regulator of transcription in E. coli. 
 
Phage-mediated RNAp inhibition and regulation has not been studied in M. tuberculosis 
therefore it is unknown whether similar mechanisms exist for phages that are specific for 
mycobacteria, termed mycobacteriophages. However, it is likely that studies similar to the 
ones described here could provide novel insights into RNAp inhibition as a means of TB 
treatment.  
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2.6 Antimicrobial Agents 
A number of compounds are known to inhibit RNAp in bacteria; however rifampicin (RIF) 
was the first drug to be used for the treatment of M. tuberculosis infections. RIF is a broad-
spectrum antibiotic which inhibits mycobacterial transcription by binding to the β-subunit of 
RNAp (71). RIF binds at a position at least 12 Å away from the active site of RNAp and 
prevents extension of RNA transcripts longer than 2-3 nucleotides (72). RIF resistant isolates 
demonstrate reduced binding of RIF to RNAp due to mutations in the rpoB gene (71) (Table 
2.2). Clusters of these mutations fall within the 81 bp sequence called the “Rifampicin 
Resistance Determining Region” (RRDR) (5). In a systematic review by Ramaswamy and 
Musser in 1998, it was found that approximately 95% of RIF-resistant isolates have point 
mutations or short insertions/deletions in this region of rpoB (5).  
 
Table 2.2 High confidence rpoB mutations linked to RIF-resistance in M. tuberculosis. 
Adapted from the TB Drug Resistance Mutation Database (TBDReaMDB) (73). 
Polymorphism Amino Acid Change Primary Reference 
CTG/CCG L511P Kapur et al, 1994 (74) 
CAA/CTA Q513L Kapur et al, 1994 (74) 
GAC/GTC D516V Kapur et al, 1994 (74) 
GAC/TAC D516Y Kapur et al, 1994 (74) 
TCG/TTG S522L Bodmer et al, 1995 (75) 
CAC/AAC H526N Ramaswamy et al, 2004 (76) 
CAC/GAC H526D Kapur et al, 1994 (74) 
CAC/TAC H526Y Kapur et al, 1994 (74) 
CAC/CGC H526R Kim et al, 1997 (77) 
CAC/CTC H526L Kapur et al, 1994 (74) 
TCG/TTG S531L Donnabella et al, 1994 (78) 
TCG/TGG S531W Bodmer et al, 1995 (75) 
CTG/CCG L533P Moghazeh et al, 1996 (79) 
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A study which investigated the mechanistic effect of different rpoB mutations, based on 
structural models of the interaction between RIF and RNAp, revealed that certain rpoB 
mutations not only prevent binding of RIF, but also reduce the affinity of RNAp for RIF 
molecules (80). In addition to hindering the intermolecular hydrogen bonds between RIF and 
its binding site, S531L and H526D mutations lead to the formation of a structural obstruction 
and a charge repulsion, respectively (Figure 2.8). As a result, it appears that these particular 
mutations aid the bacterium in a multi-pronged mechanism which may account for the high 
level of RIF-resistance which has previously been associated with S531L mutations (81). 
 
 
Figure 2.8 Structural models illustrating the interaction between a RIF molecule (depicted 
in green and red) and RNAp with S531L and H526D mutations, respectively. Hydrogen 
bonds between WT complexes are indicated by blue dotted lines. Illustration adapted from 
Pang et al (80). 
 
In some cases, mutations which confer drug resistance can be harmful to the bacterium and 
may cause a fitness cost given that they affect important cellular functions and can cause a 
metabolic burden. In numerous studies, S531L or H526Y were found to be the most frequent 
RIF-resistance conferring mutations among RIF
 
resistant clinical isolates and in vitro mutants, 
suggesting that these mutations have the smallest impact on mycobacterial fitness (82, 83). 
Gagneux and colleagues investigated the fitness cost inferred by different rpoB mutations in 
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both RIF-resistant clinical isolates of M. tuberculosis and laboratory-generated rpoB mutants 
(84). Fitness cost was calculated based on the mutant’s ability to compete for limited 
resources when in the same environment as RIF-sensitive strains. No fitness cost was detected 
in the majority of the clinical isolates harbouring a S531L mutation, which may be why this 
particular rpoB mutation is more prevalent in clinical isolates. However, a fitness cost was 
observed in all in vitro generated mutants with an rpoB mutation, albeit very slight, as in the 
case of the S531L mutant. This indicates that there are mechanisms through which               
M. tuberculosis is able to ameliorate a fitness cost when in the host, possibly due to additional 
compensatory mutations which aid bacterial survival in vivo. 
 
Gene mutations leading to a deleterious effect, as is the case with many drug resistance-
conferring mutations, can have an array of consequences, such as reduced growth and 
virulence which would ultimately lead to decreased survival. The fate of a deleterious 
mutation includes reversion to the WT form by means of the bacterial DNA repair 
mechanism; or its continuance within the population by gaining compensatory mutations 
which reduce the deleterious effect without causing a loss of the drug resistant phenotype, 
referred to as compensatory evolution. Various studies have described compensatory 
mutations in RIF resistant strains of M. tuberculosis, one of which suggested that the 
acquisition of specific mutations in rpoA and rpoC can result in the emergence of high fitness 
multidrug-resistant (MDR) strains (Figure 2.9) (85, 86). Although these mutations were 
shown to occur at high frequencies in clinical isolates, the authors of this study specify that it 
is unknown how these mutations influence the success of the bacterium. More recently, De 
Vos and colleagues investigated the epidemiological relevance of rpoC mutations in clinical 
isolates of M. tuberculosis and revealed that 23.5% of the RIF-resistant strains included in the 
study harboured a non-synonymous polymorphism in rpoC and that these putative 
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compensatory mutations were significantly associated with the rpoB S531L mutation (87). 
Various models were proposed to explain the relationship between this particular rpoB 
mutation and rpoC mutations; however additional studies are needed to elucidate the 
underlying mechanisms that are involved.  
 
 
Figure 2.9 Mutations identified in rpoA and rpoC in a number of MDR strains of        
M. tuberculosis. Colours represent different lineages, indicating that the same mutations 
are present across different strain backgrounds. Adapted from Comas et al (85). 
 
A number of other natural antibiotics that target RNAp have been discovered, one of which, 
called lipiarmycin, has recently been approved for the treatment of Clostridium difficile 
infections (88). Lipiarmycin is a macrocyclic antibiotic which has been shown to have activity 
against RIF-resistant M. tuberculosis (89, 90). The compound targets region 3.2 of σ70 as well 
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as a region called the switch-2 element on the β′ subunit of RNAp, thereby inhibiting 
formation of the RPo complex (91). Myxopyronin, corallopyronin and ripostatin are other 
drugs which bind to the switch-2 element of RNAp, indicating that this may be a promising 
drug target for treating M. tuberculosis infections (Figure 2.10) (92). 
 
 
Figure 2.10 Target sites of myxopyronin (Myx), corallopyronin (Cor), ripostatin (Rip) 
and lipiarmycin (Lpm) in the switch region of the β′ subunit of RNAp, relative to the 
region where rifamycin (Rif) resistance-conferring substitutions occur on the β subunit. 
Adapted from Srivastava et al (92).  
 
2.7 Knowledge Gaps 
2.7.1 Transcriptional Regulation 
Conditions such as cellular stress or a change in growth phase drives prokaryotes to rapidly 
modulate gene expression in order to survive. Numerous transcriptional regulators interact 
with RNAp in order to regulate gene expression as it is the primary enzyme responsible for 
transcription in prokaryotes. This review aimed to highlight a number of transcriptional 
regulators that function at the level of transcription initiation by interacting with the β and β’ 
subunits of RNAp. However, gene regulation is far more complex than the aspects discussed 
here. A better understanding of regulatory proteins that function at all levels of transcription is 
necessary to fully comprehend RNAp regulation in bacteria. Unfortunately many of these 
mechanisms remain unclear or unknown in M. tuberculosis, and prove to be a major obstacle 
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in our understanding of host-pathogen interactions. Based on the aspects described in this 
review, it is evident that well-described mechanisms of transcriptional regulation in E. coli 
appear to differ from corresponding mechanisms in M. tuberculosis. This is evident when we 
compare the factors involved in transcriptional regulation mediated by σ factors, the stringent 
response and sRNA (Table 2.3).  
 
Table 2.3 A comparison of the factors that influence transcriptional regulation in the model 
organism, E. coli, and pathogenic M. tuberculosis. 
Factors influencing 
transcriptional regulation 
E. coli M. tuberculosis 
σ factor families σ
54
 and σ70 σ70 
Number of σ factors 7 13 
Number of anti-σ factors 3 5 
Number of anti-anti-σ factors 0 2 
p/ppGpp synthesis and 
hydrolysis 
RelA and SpoT enzymes  Bifunctional RelMtb enzyme 
Transcription factor involved 
in stringent response 
DksA 
binds to secondary channel 
of RNAp; not essential 
when E. coli is growing in 
nutrient-rich environments 
CarD 
binds to N-terminus of  
β subunit; vital for 
mycobacterial viability 
under all conditions 
Effect of rpoB mutations on 
the stringent response 
Mutations at codons 331 
and 332 lead to 20-fold 
increase in intracellular 
sensitivity to p/ppGpp 
unknown 
sRNA that modulates RNAp 




downregulation of genes 
involved in exponential 
growth 
sRNA chaperone Hfq unknown 
Regulation of σ factors by 
sRNA 
DsrA sRNA binds to 
hairpin-loop of rpoS mRNA 
unknown 
Bacteriophage-encoded 
inhibitors of RNAp 
Gp2 well-characterised  unknown 
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Gaps in our understanding of M. tuberculosis physiology is highlighted in the table as it 
demonstrates a number of features which have not been studied or where functional homologs 
have not been identified in M. tuberculosis. Although E. coli has greatly improved our 
understanding of bacterial physiology, additional studies in M. tuberculosis are urgently 
needed to gain a better understanding of pathogenic bacterial characteristics such as drug 
tolerance, virulence, persistence and hypermutability. Considering the importance of 
(p)ppGpp and sRNA in transcriptional regulation, it is surprising how little is known about 
the role they play in mycobacteria. Further research could reveal the function of these poorly-
understood regulators and the effect they have on RNAp and transcriptional regulation in     
M. tuberculosis.  
 
Additionally, it is evident that the emergence of RIF-resistant TB has negatively affected TB 
control programs and the lack of a large repertoire of novel anti-TB drugs exacerbates this 
problem. A new approach to finding a sustainable solution for treating TB infections could 
emerge from investigating the mechanisms employed by phages to inhibit bacterial RNAp. 
The identification and characterization of inhibitory proteins in mycobacteriophages similar to 
the studies done in E. coli would be particularly useful in providing novel insight into RNAp 
as a drug target. Identifying compounds which mimic these inhibitory phage proteins would 
be beneficial for drug discovery and development in the global battle against drug-resistant 
TB. From past experience we know that if new RNAp-targeting drugs should be introduced 
into the current TB treatment regimen, it would be worthwhile to determine the effects of 
known resistance-conferring mutations prior to treating patients.  
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2.7.2 Understanding Mechanisms of Drug Resistance 
It is uncertain how mutations that confer RIF resistance affect RNAp function and whether 
they cause structural changes that can lead to a change in the interactions between RNAp and 
transcriptional regulators. It is possible that these mutations affect protein function by 
changing the affinity for certain transcriptional regulators, just as certain rpoB mutations lead 
to decreased affinity of RIF for RNAp, however additional studies are needed to investigate 
this. A better understanding of the physiological changes that take place as a result of 
resistance-conferring mutations is necessary to determine their influence on protein function. 
Additionally, it is central to our understanding to determine how compensatory mutations in 
RNAp are able to ameliorate the fitness cost inferred by RIF resistance-conferring mutations.  
  







Materials and Methods 
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3.1 Mycobacterial Strain Selection and Cultivation 
Clinical isolates were selected from a reference database which is maintained at Stellenbosch 
University and linked to a sample bank of well-characterized drug resistant M. tuberculosis 
isolates. The selected isolates included two RIF mono-resistant clinical isolates with different 
rpoB mutations, H526Y (n=1; C526) and S531L (n=1; C531), as well as a drug sensitive 
clinical isolate with no known resistance-conferring mutations, M0 (Table 3.1). All three 
isolates were characterized by IS6110-based restriction fragment length polymorphism 
(RFLP) and were shown to belong to closely related Beijing clusters 11427, 209 and 208, 
respectively.  
 
Both the reference strain, M. tuberculosis H37Rv, and the aforementioned drug-sensitive 
clinical isolate were used to generate in vitro mutants by spontaneous mutation using the 
Luria–Delbrück fluctuation assay [previously done by M. de Vos (PhD Thesis, 2013) and D. 
Willemse (MSc Thesis, 2013)]. Targeted sequencing was used to confirm the position of rpoB 
mutations in approximately 150 spontaneous mutants; thereafter stocks of the mutants were 
stored at -80ºC. For the purpose of this study, two RIF mono-resistant progeny from each 
progenitor strain were selected; one with a H526Y mutation and another with a S531L 
mutation. The in vitro mutants (n=4) as well as the drug-sensitive progenitors (n=2) were 
included in this study with the aim of investigating the effect of different rpoB mutations on 
the transcriptome of M. tuberculosis. 
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Table 3.1 Clinical isolates, WT progenitors and in vitro mutants selected for 
transcriptomic analysis. 
Sample Genotype Sample Type rpoB Mutation 
C526
*
 Beijing cluster 11427 clinical isolate H526Y 
C531
*
 Beijing cluster 209 clinical isolate S531L 
M526
∆
 Beijing cluster 208 in vitro mutant H526Y 
M531
∆
 Beijing cluster 208 in vitro mutant S531L 
M0
*
 Beijing cluster 208 clinical isolate (progenitor) WT 
H526
ǂ
 H37Rv in vitro mutant H526Y 
H531
ǂ
 H37Rv in vitro mutant S531L 
H37Rv H37Rv reference strain (progenitor) WT 
Legend to Table 3.1: 
* Samples selected from the clinical isolate sample bank: C526 (Isolate ID R1415); C531 
(Isolate ID R721); M0 (Isolate ID K636) 
∆ 
Samples selected from the K636 in vitro mutant depository: M526 (Sample ID N25S4); M531 
(Sample ID N36S1) 
ǂ 
Samples selected from the H37Rv in vitro mutant depository: H526 (Sample ID 74); H531 
(Sample ID 75) 
 
Clinical isolates were cultured on Löwenstein-Jensen slants in a Biosafety Level 3 (BSL-3) 
laboratory for 4-6 weeks (Appendix B); thereafter a scrape of the culture was inoculated into 
5 mL of Middlebrook 7H9 broth (Becton, Dickinson and Company, MD, USA) enriched with 
albumin dextrose catalase (ADC), glycerol and Tween 80 (Merck, Darmstadt, Germany). 
Similarly, in vitro selected mutant colonies were picked from a culture inoculated onto 
Middlebrook 7H10 agar (Becton, Dickinson and Company, MD, USA) containing 2 µg/mL 
RIF and supplemented with oleic albumin dextrose catalase (OADC). The liquid cultures 
were incubated at 37°C for 2 weeks, thereafter 10 mL of ADC-enriched Middlebrook 7H9 
broth was inoculated with 1 mL of culture and incubated at 37ºC until mid-log phase (OD600 = 
0.7 - 0.8). Cultures were inspected for contamination by inoculating blood agar plates and the 
Ziehl-Neelsen differential staining method. M. tuberculosis does not grow on blood agar 
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therefore if no contamination is present, no growth should be observed on the plates after 
incubation at 37ºC for two days. The Ziehl-Neelsen staining method is used to detect acid-fast 
bacilli, such as M. tuberculosis, by light microscopy. The primary stain, fuchsin, binds to 
mycolic acid within the mycobacterial cell wall. Subsequent decolourization with acid does 
not remove the primary stain from mycobacteria and counterstaining with methylene blue 
allows for the identification of possible contaminants. Stocks of these cultures were stored at  
-80°C in 1 mL aliquots. 
 
ADC-enriched Middlebrook 7H9 broth (50 mL) was inoculated in duplicate with 1 mL 
culture and the growth was monitored by measuring the optical density of the cultures over a 
period of 21 days. Optical density was measured using the Novaspec II spectrophotometer 
(Pharmacia Biotech, England, UK) with 1 mL cuvettes. This was done in order to generate 
growth curves for each of the strains to determine the number of days needed for cultures to 
reach mid-log phase (OD600 = 0.7 - 0.8). Once this was known, identical cultures were 
prepared to perform RNA isolation. 
 
3.2 RNA Isolation and Microarray Analysis 
3.2.1 Rifampicin Exposure Conditions 
At mid-log phase, cultures for all of the samples were incubated for an additional 24 hours in 
the absence of RIF, whereas additional cultures for M526, M531, C526 and C531 were 
exposed to 2 µg/mL of RIF (Sigma-Aldrich, St Louis, Germany) for 24 hours. The 
abovementioned cultures were set up on different days as biological triplicates in order to 
increase statistical power in subsequent data analysis steps. 
 




RNA isolation was done using the FastRNA
®
 Blue kit (MP Biomedicals LLC, CA, USA) 
according to the protocol provided by the manufacturer (Appendix C). In summary, 10 mL of 
each culture was centrifuged at 1,500 x g for 10 minutes at 4°C and the pellet resuspended in 
1 mL of RNApro solution provided in the kit. Suspensions were transferred to a 2 mL screw-
cap tube containing Lysing Matrix B and processed in a reciprocal shaker (Hybaid, UK) for 4 
consecutive runs of 25 seconds at a setting of 6.5 W with intermittent cooling on ice for 1 
minute. Tubes were decontaminated and removed from the BSL-3 laboratory and centrifuged 
at 12,000 x g for 20 minutes at 4°C. The supernatant was retained and transferred to 300 µL 
of chloroform (Sigma-Aldrich, St Louis, Germany), followed by a 5 minute incubation step at 
room temperature. Thereafter, samples were centrifuged at 12,000 x g for 10 minutes at 4°C 
and the upper phase was transferred to a tube containing 500 µL of cooled absolute ethanol 
(Sigma-Aldrich, St Louis, Germany). Samples were mixed by inversion and incubated at -
20°C for at least one hour followed by centrifugation at 12,000 x g for 30 minutes at 4°C. 
Once the supernatant was aspirated, 500 µL of cooled 75% ethanol (Sigma-Aldrich, St Louis, 
Germany) was used to wash the pellet which was air dried for 5 min and re-suspended in 50 
µL of diethylpyrocarbonate (DEPC) treated water (Ambion, Applied Biosystems, CA, USA). 
Samples were incubated for 5 minutes at room temperature to ensure efficient resuspension. 
Thereafter, aliquots were prepared and either stored at -80°C or treated with DNase as 
described below. 
 
3.2.3 DNase Treatment and Phenol:Chloroform Purification 
To remove residual genomic DNA (gDNA), samples were treated with RNase-free DNase in 
the following reaction: 10 µL of RNA, 10 µL of DEPC-treated H2O, 4 µL of DNase Buffer 
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and 4 µL of RQ1 DNase (Promega, WI, USA). The reaction mixture was incubated at 37°C 
for 30 minutes, thereafter 172 µL of DEPC-treated water and 200 µL of cooled 
phenol:chlorophorm (4:1, v/v) (Sigma-Aldrich, St Louis, Germany) were added. After mixing 
by vortex, the samples were placed on ice for 10 minutes and thereafter centrifuged for 10 
minutes at room temperature. The upper phase was retained and added to a mixture of 0.1 
volumes RNase-free sodium acetate (pH 5.2) (Sigma-Aldrich, St Louis, Germany) and 2.5 
volumes cooled absolute ethanol and incubated overnight at 4°C. Samples were centrifuged at 
12,000 x g for 30 minutes at 4°C and the resulting pellet was washed with 500 µL of cooled 
75% ethanol. Thereafter, the ethanol was decanted and the pellet was air-dried for 5 minutes 
before resuspending in 15 µL of DEPC-treated water. Aliquots of 5 µL were prepared for the 
purpose of quality assessment and the remaining RNA was stored at -80°C. 
 
3.2.4 RNA Quality Assessment 
RNA quality was determining by the A260/A230 and A260/A280 ratios, using the NanoDrop-
1000 spectrophotometer (Thermo Fisher Scientific, MA, USA). The Experion RNA StdSens 
analysis kit and automated electrophoresis station (Bio-Rad Laboratories Inc., CA, USA) 
were used according to the manufacturer’s instructions to quantify samples and evaluate RNA 
integrity based on the clarity of the 16s and 23s rRNA bands. 
 
Samples were tested for gDNA contamination by polymerase chain reaction (PCR) 
amplification of the katG gene using a 0.05 mM concentration of the published primer set 
RTB59/RTB38 (Table 3.2) in the following reaction: 10x Buffer, 2 mM MgCl2, 0.4 mM 
dNTPs, HotStarTaq DNA polymerase (Qiagen, Hilden, Germany) and RNA as template (93). 
M. tuberculosis H37Rv DNA was used as the template for positive controls and water was 
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added to negative controls. PCR amplification was performed under the following conditions: 
95°C for 15 min; 35 cycles of 94°C for 1 min, 62°C for 1 min and 72°C for 1 min; followed 
by 72°C for 10 min. The PCR products were separated by electrophoresis using a 1.5% 
agarose (Sigma-Aldrich, St Louis, Germany) gel run in 1x TBE buffer (pH 8.3) at 150V for 1 
hour and visualized with a Kodak Digital Science Electrophoresis Documentation and 
Analysis System (Vilber Lourmat, France).  
 
Table 3.2 The primer set used for amplification of genomic DNA to determine the presence 






RTB59 5’ TGGCCGCGGCGGTCGACATT 3’ 
419 62 
RTB38 5’ GGTCAGTGGCCAGCATCGTC 3’ 
 
3.2.5 Aminoallyl-Tagged cDNA Synthesis and Probe Preparation 
Aminoallyl-tagged complementary DNA (cDNA) synthesis and probe preparation was done 
according to the protocol available from The Institute for Genomic Research (94). A volume 
of 2 µL random hexamer primers (3 µg/µL) was added to 1 µg of total RNA to give a final 
volume of 18.5 µL. After mixing by vortex, samples were incubated for 10 minutes at 70°C 
and placed on dry ice for 1 minute. Thereafter, each sample was added to the following 
reaction mix: 6 µL of 5x first strand buffer, 3 µL of 0.1 M DTT, 1.2 µL of 50 x aminoallyl-
dNTP mix, 2 µL of SuperScript II reverse transcriptase (Invitrogen, CA, USA); and incubated 
at 42°C overnight. A volume of 10 µL of 1 M sodium hydroxide and 10 µL of 0.5 M EDTA 
was added to the mix and incubated at 65°C for 15 minutes to hydrolyse the RNA. The 
reaction was neutralized by adding 25 µL of Tris-HCl (pH 7.4) and samples underwent two 
purification steps to remove unincorporated nucleotides and unreacted Cy dye, respectively. 
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This was done using a QIAquick PCR purification kit (Qiagen, Hilden, Germany) according 
to the instructions provided by the manufacturer with certain modifications. The buffers 
supplied in the QIAquick kit contain free amines which compete with the Cy dye esters in the 
coupling reaction, therefore phosphate wash buffer (5 mM KPO4, 80% EtOH) and phosphate 
elution buffer (4 mM KPO4) were used in the first purification step. 
 
Purification step 1 followed by Cy Dye coupling: 
A volume of 300 µL phosphate buffer (pH 8.5-8.7) was added to the cDNA samples before 
centrifuging at 18,000 x g for 1 minute in a column. Samples were washed twice with 750 µL 
of phosphate wash buffer, followed by a final centrifugation step to remove excess buffer. 
Columns were transferred to a collection tube and incubated for 1 minute at room temperature 
with 50 µL of phosphate elution buffer. Thereafter, samples were centrifuged and placed in a 
centrifugal evaporator (SpeedVac, Thermo Fisher Scientific, MA, USA) for 1 hour. 
Subsequently, samples were resuspended in 4.5 µL of 0.1 M sodium carbonate buffer and 
coupled to Cy dyes by adding 4.5 µL of N-hydroxysuccinimide ester Cy3 or Cy5 (Amersham, 
NJ, USA) and incubating in the dark for 1 hour at room temperature. 
 
Purification step 2: 
A volume of 35 µL 100 mM sodium acetate (pH 5.2) and 500 µL of Buffer PB were added to 
the labelled cDNA and transferred to a column to be centrifuged at 18,000 x g for 1 minute. 
Samples were washed twice with 750 µL of Buffer PE, followed by a final centrifugation step 
to dry the columns before transferring to the collection tubes. Probes were eluted by adding 
25 µL of Buffer EB and incubating for 1 minute at room temperature before centrifuging. 
This step was repeated before placing samples in a centrifugal evaporator for approximately 1 
hour or until completely dry. 
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3.2.6 Microarray Hybridization 
The following steps were done using the NimbleGen Hybridization kit (Roche Applied 
Science, Germany) according to the manufacturer’s instructions. Each set of probes were 
resuspended in the following reaction mix: 4.5 µL of 2x Hybridization Buffer, 1.8 µL of 
Hybridization Component A, 0.2 µL of Alignment Oligo and 2 µL of water. After mixing by 
vortex, samples were placed in a thermocycler and incubated at 95°C for 5 minutes, followed 
by a second incubation step at 42°C for at least 5 minutes. 
 
A 12x135K NimbleGen microarray slide (Roche Applied Science, Germany) was assembled 
using the Precision Mixer Alignment Tool and placed on a 42°C heating block for 5 minutes. 
Each slide comprises of 12 identical arrays of 135,000 60-mer oligonucleotide probes 
covering approximately 4000 open reading frames in the M. tuberculosis H37Rv genome. A 
volume of 6 µL of each sample was loaded into the chambers and the mixer-slide assembly 
was placed in a NimbleGen hybridization system at 42°C for 16 to 20 hours.  
 
After incubating in the hybridization system, the mixer-slide assembly was placed in the 
Mixer Disassembly Tool in 270 mL of Wash I which was preheated to 42°C. While 
submerged, the mixer was removed from the slide and washed with Wash I, II and III 
prepared according to the manufacturer’s instructions. The slide was dried with a slide spinner 
(Sigma-Aldrich, St Louis, Germany) and scanned at 5 µm resolution using a GenePix 400B 
scanner (Molecular Devices, CA, USA) with GenePix software version 6.0.  
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3.2.7 Transcriptomic Analysis 
NimbleScan software (Roche Applied Science, Germany) was used to burst each scanned 
image into 24 individual arrays and calculate spot intensities. Data was imported for robust 
multichip average (RMA) normalization and statistical analysis using ArrayStar Version 4.1.0 
(DNASTAR Inc., WI, USA). Following Benjamini Hochberg multiple testing correction, a 
Student’s t-test p-value of <0.05 was used to determine statistical significance and a mean 
log2 fold change of >1.0 across 3 replicates was used as a cut-off for differential expression. A 
log-transformed fold change of 1.0 corresponds to a non-transformed fold change of 2.0, 
which is the commonly used threshold for differential gene expression. Furthermore, a linear 
correlation test was done to determine R
2
 values among sample replicates.  
 
3.2.7.1 The Effect of Different rpoB Mutations on Global Gene Expression  
Firstly, in vitro selected mutants and progenitors were compared to investigate the effect of a 
particular rpoB mutation on the expression profile of M. tuberculosis. In order to do this, the 
following expression ratios were calculated: 
 H37Rv compared to the in vitro selected mutants generated from H37Rv 
(H526/H37Rv; H531/H37Rv) 
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3.2.7.2 The Effect of Genetic Background on Gene Expression in rpoB Mutants 
Furthermore, the following ratios were calculated in order to determine whether the same 
transcriptomic trend can be seen in the expression profiles of rpoB mutants with different 
genetic backgrounds: 
 M526 compared to M531 (in vitro mutants generated from M0) 
 H526 compared to H531 (in vitro mutants generated from H37Rv) 
 C526 compared to C531 (RIF-resistant clinical isolates) 
 
3.2.7.3 Transcriptomic Response to Rifampicin Exposure  
Expression profiles for all RIF exposed and control samples were compared to determine the 
effect of exposing RIF mono-resistant M. tuberculosis to 2 µg/mL of RIF for 24 hours. The 
ratios calculated for this comparison were as follows: 
 in vitro mutants exposed to RIF compared to the unexposed controls 
(M526 exposed/M526 unexposed; M531 exposed/M531 unexposed) 
 clinical isolates exposed to RIF compared to the unexposed controls 
(C526 exposed/C526 unexposed; C531 exposed /C531 unexposed) 
 
3.3 DNA Isolation and Whole Genome Sequencing 
3.3.1 DNA Isolation 
For the purpose of whole genome sequencing, DNA was extracted from samples M0, M526, 
M531, H37Rv, H526 and H531 as previously described (95). In summary, 100 µL of each 
isolate stock culture was inoculated onto two petri dishes (140 mm diameter) of OADC-
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enriched 7H10 Middlebrook agar and incubated for two weeks at 37°C. The petri dishes were 
placed in a pre-warmed fan oven for 1 hour at 80°C in order to heat-inactivate the bacteria. 
Thereafter, colonies were scraped from the surface of the media and transferred to a 50 mL 
tube containing 6 mL of extraction buffer (25 mM EDTA, 50 mM Tris-HCl pH 7.4, 5% 
sodium glutamate) and ± 20 glass beads with a diameter of 5 mm. The cellular suspension 
was mixed by vortex to disrupt bacterial colonies whereafter 50 mg of lysozyme (Roche 
Applied Science, Germany) and 25 μg of RNase A (Roche Applied Science, Germany) were 
added and incubated for 2 hours at 37°C. Subsequently, 650 μL of 10x Proteinase K buffer 
(100 nM Tris-HCl (pH 7.8), 50 mM EDTA, 5% sodium dodecyl sulphate) and 300 µL of 
Proteinase K (10 mg/mL) were added and incubated for 16 hours at 45°C. An equal volume 
of phenol/chloroform/isoamyl alcohol (24:23:1) was added and the suspension incubated at 
room temperature with mixing every 30 minutes over a period of 2 hours. After centrifuging 
for 20 minutes at 1800 x g, the aqueous phase was aspirated and added to 5 mL of 
chloroform/isoamyl alcohol (24:1). The suspension was centrifuged again for 20 minutes at 
1800 x g and the top phase transferred to 600 μL of 3 M sodium acetate (pH 5.2) and 7 mL of 
ice-cold isopropanol. Precipitated DNA was immediately collected on a glass rod and 
incubated for 10 minutes in 1 mL of 70% ethanol, thereafter redissolved in 300 μL of TE 
buffer (1mM EDTA, 10 mM Tris-HCl pH 8.0) and stored at -20°C. DNA quality and quantity 
were determined spectrophotometrically using the NanoDrop-1000. 
 
3.3.2 Whole Genome Sequencing  
Whole genome sequencing of the drug-sensitive clinical isolate (M0), reference strain 
(H37Rv) and in vitro selected mutants (H531, H526, M526) was done at the Central 
Analytical Facility at Stellenbosch University using the Ion Torrent PGM Sequencer (Life 
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Technologies, CT, USA). The computational analysis for in vitro selected mutant M531 
differed slightly from the pipeline described below (Figure 3.1) since it was sequenced using 
version 1.5 of the Illumina sequencing platform (Illumina, CA, USA) [M. de Vos (PhD thesis, 
2013)]. 
 
3.3.3 Quality Assessment  
FASTQ files for each of the genomes were generated and FastQC software (Babraham 
Institute, UK) was used to assess the quality of the raw sequence reads. FastQC software 
evaluates various aspects of the raw data and produces results in HTML format.  A number of 
parameters are considered during quality control analysis such as sequence quality, sequence 
content and the level of sequence duplication. FastQC generates a detailed report which 
provides a warning if quality scores are below that of the pre-set parameters. Furthermore, 
basic statistics such as read length, total number of reads processed and percentage GC 
content are also included in the report.  
 
3.3.4 Computational Analysis 
Based on the abovementioned quality assessment, the raw sequence reads were trimmed by 
27 bp using PRINSEQ-lite (http://prinseq.sourceforge.net).  This was done to remove poor 
quality sequences at the end of longer reads which may negatively influence sequence 
alignment and downstream analysis. The reference genome, M. tuberculosis H37Rv (obtained 
from TB Database, TBDB; http://genome.tbdb.org) was indexed using Tmap. This mapping 
software, specifically designed for Ion Torrent data, was also used to align the sequence reads 
to the reference genome using the “mapall” function. The resulting file is in Sequence 
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Alignment/Map (SAM) format, which was converted to Binary Alignment/Map (BAM) 
format using SAMtools software (http://samtools.sourceforge.net). Likewise, SAMtools was 
used to sort and index the BAM files as well as assess the percentage mapped reads using the 
“flagstat” function. Genome Analysis Toolkit (GATK) was used for calling in/dels within the 
genome and two variant callers, SAMtools and GATK, were used to identify SNPs 
(highlighted in green in Figure 3.1). The resulting files were provided in variant caller format 
(VCF).  The pipelines for the SNP callers are identical with the exception of a local 
realignment step when using GATK (highlighted in red in Figure 3.1). This step was 
necessary to correct for misalignments across deletions, an error which may occur when the 
alignment is performed. 
 
The SNPs identified by both the callers were extracted from the respective VCF files using in-
house python scripts (M. Daya, Department of Biomedical Sciences, Stellenbosch 
University). This was done in order to minimize the number of false positives identified by 
the individual SNP callers. As only GATK was used for calling in/dels, it was not necessary 
to overlap the variants in this way. In-house Perl scripts (M. de Vos, Department of 
Biomedical Sciences, Stellenbosch University) were used to annotate the identified SNPs and 
in/dels and those with a quality value of more than 1000 were investigated using 
GenomeView software (www.genomeview.org). 
 




Figure 3.1 Summary of the computational analysis pipeline used to identify variants in 
whole genome sequence data (software, function). 
 
3.3.5 Validation of Variants 
To confirm the presence of high-confidence SNPs, PCR primers were designed to amplify the 
genomic regions containing the respective SNPs (Table 3.3). PCR amplification was done as 
described in section 3.2.4 and the resulting amplicons were purified and sequenced using the 
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Sanger sequencing method on the ABI PRISM DNA Sequencer, Model 377 at the Central 
Analytical Facility, Stellenbosch University. DNA sequences were aligned to the reference 
genome of M. tuberculosis H37Rv using BioEdit version 7.0.5.3 (available from 
www.mbio.ncsu.edu/bioedit/bioedit.html). SNPs that were identified by whole genome 
sequencing and validated by Sanger sequencing were considered to be present in the genome 
of the respective M. tuberculosis isolates. 
 
Table 3.3 Primers used to validate high confidence SNPs identified through whole genome 
sequencing of in vitro selected mutants (H526; H531; M526; M531). 






Forward: 5’ GATCCAGGCGAGGTGATG 3’ 
544 
60.16 
Reverse: 5’ CGGTGGATACCACCAACACT 3’  60.59 
lipM 
Forward: 5’ GAGCGAATGGTGGTCAAACA 3’ 
372 
62.05 
Reverse: 5’ CAACCCTAGCGACCTCAACC 3’ 61.96 
trmB 
Forward: 5’ GTAGGGCTACGTCCCGACAC 3’ 
431 
61.86 
Reverse: 5’ AAGACTCGAACACCGCACAA 3’ 61.83 
 
 
3.3.6 Bioinformatic Analysis of Non-Synonymous SNPs 
To determine whether validated  non-synonymous SNPs influence protein structure, models 
of the respective proteins were generated using SWISS-MODEL and visualized using the 
PyMOL Molecular Graphics System, Version 1.1 Schrödinger, LLC (96). A QMEAN Z-score 
was generated by the SWISS-MODEL workspace and was used to estimate the absolute 
quality of the protein models. This score takes 4 statistical potential scores into account 
(torsion potential, solvation potential, all-atom interaction potential and C-β interaction 
potential) and ranges from 0 to 1; with a higher score indicating a more reliable model (97). 
Amino acid sequences were also submitted to SIFT (Sorting Intolerant From Tolerant; 
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http://sift.bii.a-star.edu.sg) to predict whether the respective polymorphisms influence protein 
function (98). SIFT generates a score based on sequence homology and amino acid properties 
which represents the normalized probability that a particular amino acid change is tolerated, 
with a score of <0.05 indicating deleterious polymorphisms. 
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4.1 Growth Curves 
Growth curves were constructed for each of the isolates to determine the number of days 
required for the cultures to reach mid-log phase (Figure 4.1). Cultures were incubated for 
approximately 5 to 13 days before reaching an OD600 of 0.7 - 0.8 (highlighted in blue shading 
on graph). It was found that WT H37Rv demonstrated a faster growth rate as compared to the 
in vitro mutants H531 and H526. A similar trend was seen for the clinical progenitor isolate, 
M0, as compared to the in vitro mutant M531. Clinical isolates, C531 and C526, showed a 
slower growth rate, taking between 9 and 14 days to reach mid-log phase. 
 
 
Figure 4.1 Growth curves for progenitors (H37Rv; M0); in vitro selected mutants (H526; 
H531; M526; M531) and clinical isolates (C526; C531). Error bars represent standard 
deviation between duplicates. 
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4.2 RNA Isolation and Microarray Analysis 
4.2.1 RNA Quality Assessment 
Figure 4.2a shows the integrity of the isolated RNA after fractionation using the Experion 
automated electrophoresis system. The RNA was assessed for gDNA contamination by PCR 
amplification of the katG gene. No PCR products were present after fractionation by agarose 
gel electrophoresis, confirming the absence of DNA contamination in the isolated RNA 
(Figure 4.2b). The concentrations for the purified RNA samples (n=36) ranged from 95.68 - 
880.87 ng/µL (Appendix D). 
 
 
Figure 4.2 (a) Fractionation of purified RNA to determine its integrity according to the 
clarity of the 16s and 23s rRNA bands. (b) Electrophoretic fractionation of the katG PCR 
amplification product. A: RNA samples; B: negative controls C: positive controls. 
      
 
4.2.2 The Effect of rpoB Mutations on Global Gene Expression 
Expression ratios were calculated in order to evaluate the effect of different rpoB mutations 
on the gene expression profiles of the respective M. tuberculosis strains. Two sets of WT 
progenitors and in vitro selected spontaneous mutants were available for this comparison: 
H37Rv/H526/H531 and M0/M526/M531, respectively. A cross-correlation revealed the 
similarity between the expression profiles, with R
2
 values closer to 1 indicating greater 
similarity between samples. Table 4.1 illustrates the R
2
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0.86 - 0.96. Clinical isolates C526 and C531 were not included in this analysis as WT 
progenitor strains were not available for these isolates. 
 
Table 4.1 Cross-correlation R
2
 values for each of the WT progenitors and in vitro 
selected mutants once biological replicate datasets were grouped. Red shading 
indicates R
2
 values closer to 1.00. 
 
H37Rv H526 H531 M0 M526 M531  
H37Rv ----- 0.95 0.96 0.84 0.73 0.71  
H526 0.95 ----- 0.93 0.84 0.75 0.70  
H531 0.96 0.93 ----- 0.82 0.74 0.73  
M0 0.84 0.84 0.82 ----- 0.90 0.86  
M526 0.73 0.75 0.74 0.90 ----- 0.90  
M531 0.71 0.70 0.73 0.86 0.90 -----  
 
 
4.2.2.1 Drug-Sensitive Clinical Isolate and In Vitro Selected Mutants 
Data in table 4.1 showed that progenitor M0 varied considerably from in vitro mutants M526 
and M531 (R
2
 values 0.86-0.90), unlike the H37Rv progenitor and its corresponding mutant 
clones, which were very similar (R
2
 values 0.93-0.96). Due to this discrepancy, dataset M0 
was excluded from subsequent analyses. 
 
4.2.2.2 H37Rv and In Vitro Selected Mutants 
Comparing WT H37Rv to each of the rpoB mutants revealed a total of 65 and 100 genes 
which were differentially expressed with a p-value of >0.05 and a log2-transformed fold 
change of >1.0 (equivalent to a non-transformed fold change of >2.0) in H526 and H531, 
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respectively. The majority of these differentially expressed genes were found to be 
downregulated in both rpoB mutants (Figure 4.3) 
 
 
Figure 4.3 Distribution of significantly differentially expressed genes in rpoB 
mutants (H526, H531) with reference to WT progenitor H37Rv, grouped 
according to fold change. 
 
Subsequently, differentially expressed genes with a log2 fold change of >1.0 were grouped 
into functional categories according to TubercuList (http://tuberculist.epfl.ch/) to determine 
the groups of genes whose transcription were most affected by the rpoB mutations (Figure 
4.4). The majority of the differentially expressed genes were found to encode for hypothetical 
proteins, followed by proteins involved in intermediary metabolism and respiration; and cell 
wall and cell processes. In 7 of the 10 functional categories, a greater number of genes were 
downregulated in H531 compared to H526, which correlates with the representation of 
downregulated genes in Figure 4.3. 




Figure 4.4 Significantly up- and downregulated genes (log2 fold change >1.0) in rpoB 
mutants (H526, H531) relative to expression in the WT progenitor (H37Rv) grouped 
according to functional categories. 
 
It was noted that a number of transcriptional regulators were differentially expressed in each 
of the rpoB mutants. Table 4.2 provides an overview of 2 regulators which were upregulated 
in H526 and 7 which were downregulated in H531, as depicted in the “Regulatory” category 
in Figure 4.4.  Interestingly, WhiB7 was the only transcriptional regulator that was 
differentially expressed in both mutants, albeit in opposite directions (Table 4.2). 
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Table 4.2 Differentially expressed transcriptional regulators identified when comparing 
expression profiles of rpoB526 and rpoB531 mutants with that of WT H37Rv. 






Rv1816 +1.24 - 
Rv3197A 
(whiB7) +1.34 
Plays a role in redox homeostasis and intrinsic 






Rv0792c -1.26 - 
Rv1167c -1.09 In an operon with lipX  (PE11) 
Rv1395 -1.64 Involved in cytochrome P450 regulation (100) 
Rv2912c -1.74 
In an operon with Rv2913c which encodes         
D-amino acid hydrolase 
Rv3082c 
(virS) -1.16 




Plays a role in redox homeostasis and intrinsic 
drug resistance (99) 
Rv3833 -1.07 - 
 
When comparing the expression profiles of the two rpoB mutants, it was found that only 8 
genes were differentially expressed in both (Figure 4.5).  Rv0789c-Rv0791c (hypothetical 
proteins), Rv1131 (probable methylcitrate synthase) and Rv3453 (conserved transmembrane 
protein) were downregulated in both mutants, whereas Rv3197A (whiB7), Rv1258c (tap) and 
Rv2416c (eis) were upregulated in H526 and downregulated in H531. This was a striking 
observation as WhiB7 regulates both tap and eis in M. tuberculosis. Other genes which have 
been found to play a role in the WhiB7 regulon include Rv2725c (hflx), Rv1988 (erm) and 
Rv2301 (cut2) (103). Upon closer inspection it was discovered that these genes followed the 
same trend as whiB7 in the two rpoB mutants (Table 4.3) 
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Figure 4.5 Venn diagram illustrating the distribution of 
significantly differentially expressed genes in different rpoB 
mutants (H526, H531) compared to WT progenitor H37Rv. 
 
Table 4.3 Differential expression of genes that are part of the WhiB7 regulon.  
LOCUS GENE GENE PRODUCT 
FOLD CHANGE (log2) 
H526/H37Rv H531/H37Rv 
Rv1258c tap membrane transport protein 1.15 -2.05 
Rv1988 erm methyltransferase (0.99) -0.90 
Rv2301 cut2 cutinase (0.38) -0.86 
Rv2416c eis enhanced intracellular survival protein 1.44 -1.79 
Rv2725c hflx GTP-binding protein 0.98 -0.40 
Rv3197A whib7 transcriptional regulator 1.34 -2.03 
Legend to Table 4.3: Values in parentheses indicate an expression ratio with a p-value of >0.05. 
 
In order to investigate other cellular pathways which may be influenced by the two different 
rpoB mutations, the lists of differentially expressed genes were submitted to KEGG Mapper 
(http://www.genome.jp/kegg/tool/map_pathway1.html). To gain a better perspective of global 
gene expression in the mutants, a log2 fold change threshold of >0.5 was used in order to 
include a greater number of genes in this analysis. The KEGG PATHWAY database includes 
7 global metabolic maps for M. tuberculosis. Table 4.4 gives an overview of the number of 
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differentially expressed genes involved in each of these major pathways. A closer look at the 
sub-categories of the global pathways (listed in Appendix E) revealed a vast number of 
pathways that were downregulated in H531. Pathways where at least 10 genes were involved 
include: limonene and pinene degradation (n=15); propanoate metabolism (n=13); butanoate 
metabolism (n=13); geraniol degradation (n=11); valine, leucine and isoleucine 
degradation (n=11); fatty acid metabolism (n=10) and tryptophan metabolism (n=10). 
 
Table 4.4 The number of differentially expressed genes involved in each of the global 
metabolic pathways according to the KEGG PATHWAY database for M. tuberculosis. 
Global Pathway 
Number of Differentially Expressed Genes 
(log2 fold change > 0.50; p-value < 0.05) 
↑H526 ↓H526 ↑H531 ↓H531 
Metabolic pathways 6 29 13 65 
Biosynthesis of secondary metabolites 3 21 9 42 
Microbial metabolism in diverse environments 2 10 4 37 
Carbon metabolism 2 7 2 11 
Biosynthesis of amino acids  - 6 5 6 
2-Oxocarboxylis acid metabolism  - - - 4 
Degradation of aromatic compounds - - - - 
 
4.2.3 The Effect of Genetic Background on Gene Expression in rpoB Mutants  
To determine whether the respective rpoB mutations caused similar transcriptomic changes in 
both in vitro selected mutants and closely related clinical isolates, the expression profiles for 
all the rpoB mutant sets (H526/H531; M526/M531 and C526/C531) were compared and 
analysed (Figure 4.6). As progenitors were not included in this analysis, gene expression in 
the rpoB526 mutants is relative to the gene expression in the rpoB531 mutant, unless stated 
otherwise. 




Figure 4.6 Scatter plots illustrating global gene expression when 
comparing data sets A: H526/H531; B: M526/M531 and C: 
C526/C531. White dots bordering parallel green lines represent 




Figure 4.7 shows 218 (H526/H531); 477 (M526/M531); and 552 (C526/C531) genes were 
differentially expressed in each of the comparisons, respectively. This indicates that a greater 
number of genes were differentially expressed in the clinical isolates (C526; C531) and in 
vitro mutants (M526; M531) generated from a drug-sensitive clinical isolate compared to the 
in vitro mutants generated from H37Rv. 




Figure 4.7 Distribution of significantly differentially expressed genes in 




Figure 4.8 gives an illustration of these genes when grouped according to functional 
categories. Similar to the previous progenitor-mutant analysis, the majority of differentially 
expressed genes were in the conserved hypothetical, intermediary metabolism and respiration, 
and cell wall and cell processes categories across all three comparisons. In 9 of the 10 
functional categories, a larger number of genes were differentially expressed in mutant sets 
C526/C531 and M526/M531 compared to mutant set H526/H531. 




Figure 4.8 Distribution of differentially expressed genes when comparing rpoB526 
and rpoB531 mutants across different genetic backgrounds, grouped according to 
functional categories. 
 
A three-way comparison of the datasets showed that 28 genes were commonly differentially 
expressed (up- or down-regulated in both sets) in all rpoB526 mutants relative to the rpoB531 
mutants (Figure 4.9). Only genes which were consistently upregulated or consistently 
downregulated were included in overlapping subsets to demonstrate a common trend among 
samples with the same rpoB mutation. Differentially expressed genes in the H526/H531 
comparison had 62 and 58 genes in common with mutant sets M526/M531 and C526/C531, 
respectively. However, 149 genes were commonly differentially expressed in M526/M531 
and C526/C531 gene sets, which is an indication of the similarity between samples with a 
clinical genetic background. 




Figure 4.9 Distribution of significantly differentially 
expressed genes across three sets of rpoB mutants 
(H526/H531; M526/M531 and C526/C531). Only genes 
which were up/downregulated in all compared datasets 
were included in overlapping subsets. 
 
Two operons were found in the group of 28 genes which were differentially expressed in all 
mutant sets, both playing a role in intermediary metabolism and respiration (Table 4.5). The 
operon comprising of Rv1121 (zwf1) and Rv1122 (gnd2) was upregulated in the rpoB531 
mutants, whereas Rv3001c (ilvC), Rv3002c (ilvN) and Rv3003c (ilvB1) were downregulated. 
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Table 4.5 Commonly differentially expressed genes when comparing all three sets of rpoB 
mutants (H526/H531; M526/M531; C526/C531). Operons referred to in text are highlighted 
in red.  
FC* LOCUS PRODUCT 








Rv0950c conserved hypothetical protein -1.01 -2.02 -1.99 
Rv1535 hypothetical protein +1.52 +1.24 +1.39 
Rv1883c conserved hypothetical protein +1.01 +1.59 +1.35 
Rv1907c hypothetical protein +1.33 +1.62 +2.20 
Rv1947 hypothetical protein -1.33 -1.70 -2.53 
Rv2271 conserved hypothetical protein -1.12 -1.21 -2.67 
Rv2960c hypothetical protein -1.11 -1.12 -1.21 
Rv3074 conserved hypothetical protein +1.42 +1.03 +1.72 
Rv3288c hypothetical protein (UsfY) +1.25 +1.17 +1.25 
Rv3647c conserved hypothetical protein +1.74 +1.71 +2.45 
2 
Rv1121 glucose-6-phosphate 1-dehydrogenase (Zwf1) -1.27 -1.80 -1.73 
Rv1122 6-phosphogluconate dehydrogenase (Gnd2) -1.18 -1.97 -1.96 
Rv1412 riboflavin synthase alpha chain (RibC) +1.30 +1.02 +1.15 
Rv2918c protein-pii uridylyltransferase (GlnD) -1.17 -1.31 -1.25 
Rv3001c ketol-acid reductoisomerase (IlvC) +1.51 +1.68 +1.65 
Rv3002c acetolactate synthase small subunit (IlvN) +1.49 +1.74 +1.58 
Rv3003c acetolactate synthase large subunit (IlvB1) +1.65 +1.97 +1.92 
Rv3247c thymidylate kinase (Tmk) +1.24 +2.78 +1.56 
3 
Rv0686 membrane protein +1.72 +1.90 +1.73 
Rv1184c hypothetical exported protein -1.04 -2.29 -3.41 
Rv1686c conserved membrane protein +1.34 +1.01 +1.65 
Rv2253 secreted protein +1.61 +3.83 +1.42 
Rv3289c transmembrane protein +1.34 +2.37 +2.74 
4 
Rv1080c transcription elongation factor (GreA) +1.33 +1.90 +1.38 
Rv3202c ATP-dependent DNA helicase +1.48 +1.23 +1.10 
5 
Rv0891c transcriptional regulator -1.11 -1.64 -2.98 
Rv3197A transcriptional regulator whib-like (WhiB7) +3.38 +5.02 +2.56 
6 Rv3385c possible antitoxin (VapB46) +1.15 +1.29 +1.70 
Legend to Table 4.5: *Functional Categories: 1 - Conserved hypothetical; 2 - Intermediary metabolism 
and respiration;   3 - Cell wall and cell processes; 4 - Information pathways; 5 – Regulatory;                  
6 - Virulence, detoxification and adaptation. 
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As highlighted in Table 4.5, whiB7 is downregulated by a log2 fold change of 2.57-5.02 in all 
three rpoB531 mutants. Parallel to the findings in the progenitor-mutant analysis, genes which 
have been shown to form part of the WhiB7 regulon display a similar trend in the rpoB 
mutants across different genetic backgrounds (Table 4.6). 
 
Table 4.6 Expression ratios of genes that are part of the WhiB7 regulon when comparing 
samples with different rpoB mutations.  
LOCUS GENE GENE PRODUCT 







Rv1258c tap membrane transport protein 3.21 2.52 (0.61) 
Rv1988 erm methyltransferase 1.89 1.40 0.87 
Rv2301 cut2 cutinase 1.23 (0.53) 0.69 
Rv2416c eis enhanced intracellular survival protein 3.23 3.24 (0.55) 
Rv2725c hflx GTP-binding protein 1.38 1.39 0.86 
Legend to Table 4.6: Values in parentheses indicate an expression ratio with a p-value of >0.05. 
 
4.2.4 Transcriptomic Response to Rifampicin Exposure 
Expression profiles of all RIF exposed (M526; M531; C526; C531) and control samples were 
compared to determine the effect of exposing RIF-resistant clinical isolates and in vitro 
selected mutants to the critical concentration (2µg/mL) of RIF. No significant differential 
expression was observed in any of the comparisons as demonstrated in the scatterplots in 
Figure 4.10. 
 




Figure 4.10 Scatterplots illustrating no significantly differential gene 
expression in cultures exposed to 2 µg/mL RIF for 24 hours 
compared to unexposed cultures. 
 
4.3 Whole Genome Sequencing 
4.3.1 Quality Control 
Whole genome sequencing of the drug-sensitive progenitor strains (M0; H37Rv) and in vitro 
selected mutants (H531; H526; M526) was done to determine whether the in vitro mutants 
harbour additional SNPs (besides known rpoB mutations) or short in/dels which may 
influence gene expression. FastQC reports were generated for each the sequenced genomes in 
order to assess the quality of the raw sequence reads (Appendix F). Once quality control 
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parameters and basic statistics were examined and found to be satisfactory, data was used for 
subsequent computational analysis (Table 4.7). 
 
Table 4.7 Basic statistics for whole genome sequences provided by SAMTools and FastQC. 
 M0 M526 M531
∆
 H37Rv H526 H531 
GC Content (%) 62 62 63 62 63 63 
Mapping Coverage (%) 96.71 95.85 70.98 98.65 98.27 98.73 
Number of Reads 
Mapped 
4582019 4098689 18541342 4368072 5276570 5199461 
Mean Read Length (bp) 202 177 100 197 203 210 
Coverage Depth* (fold) 209.81 164.45 420.29 195.06 242.81 247.51 
Legend to Table 4.8: *Coverage depth = (number of reads mapped x mean read length)/4411532 
              
∆
Sequenced on the Illumina sequencing platform (all other samples sequenced 
              using the Ion Torrent PGM Sequencer) 
 
4.3.2 Computational Analysis 
The genomes were aligned to the H37Rv reference genome prior to comparing mutant 
genomes to the respective progenitors (Table 4.8). SNP analysis confirmed that the rpoB 
mutation was present in M526 with no other SNPs or in/dels being found in this sample when 
compared to M0. For M531, an additional synonymous SNP was observed in TB16.3 
(Rv2185c). Furthermore, a non-synonymous SNP was found in each of the in vitro mutants 
generated from H37Rv: a P379L polymorphism in Rv2284 (esterase) was identified in H526 
and a Y109D polymorphism in Rv0208c (probable methyltransferase) was seen in H531. 
Once confirmed in GenomeView, these high-confidence SNPs were validated by PCR 
amplification and Sanger sequencing of the target regions, as described in section 3.3.5 (Table 
4.9).  
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Table 4.8 Selection criteria used for the identification of SNPs and in/dels in in vitro selected 
mutants (M526; M531; H526; H531) compared to the respective progenitors (M0; H37Rv). 
 
M526 M531 H526 H531 
Sequencing Platform Ion Torrent Illumina Ion Torrent Ion Torrent 
SNPs called by GATK and SAMtools 
(Compared to H37Rv) 
1383 1531 98 93 
Unique to mutant 
(SNPs not found in progenitor) 
83 38 11 9 
Quality value ≥1000 30 9 3 2 
Confirmed in GenomeView 1 2 2 2 
Validated by Sanger sequencing 1 2 2 2 
In/dels called by GATK 
(Compared to H37Rv) 
2579 139 54352 53358 
Unique to mutant 
(In/dels not found in progenitor) 
982 5 26821 26343 
Quality value ≥1000 2 5 1926 2368 
Confirmed in GenomeView 0 0 0 0 
 
Table 4.9 Validated SNPs identified through bioinformatic analysis of in vitro selected 
mutants (H526; H531; M526; M531). 
Sample Locus Gene Gene Product SNP Amino Acid Change 
M526 Rv0667 rpoB β-subunit RNA polymerase C → T H445Y* 
M531 
Rv0667 rpoB β-subunit RNA polymerase C → T S450L* 
Rv2185c TB16.3 hypothetical protein A → C G101G 
H526 
Rv0667 rpoB β-subunit RNA polymerase C → T H445Y* 
Rv2284 lipM esterase C → T P379L 
H531 
Rv0667 rpoB β-subunit RNA polymerase C → T S450L* 
Rv0208c trmB putative methyltransferase T → G Y109D 
Legend to Table 4.10: *Codon positions 445 and 450 in M. tuberculosis correspond to codon 
position 526 and 531 in the gene sequence of E. coli. 
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A protein model was generated to determine whether the non-synonymous SNP in trmB 
(Rv0208c) could influence the structure of the gene product, a putative methyltransferase 
(Figure 4.11). The sequence identity for this model was 34.74%, with a QMEAN4 Z-score of 
0.66 which indicates that this is a medium-accuracy model. The sequence identity and 
QMEAN4 Z-score for the LipM model was much lower (26.39% and 0.33, respectively) 
therefore a reliable 3D protein model could not be generated to visualize the position of the 
polymorphism in lipM. Lastly, amino acid sequences were submitted to SIFT which predicted 
that the polymorphisms in both trmB and lipM would affect protein function with scores of 
0.02 and 0.00, respectively. 
 
 
Figure 4.11 Protein model illustrating the amino acid change, tyrosine (A) to aspartic acid 
(B), caused by the polymorphism in trmB. Amino acid side chains are illustrated in white. 
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The present study is the first of its kind to investigate the effect of rpoB mutations on global 
gene expression in both clinical isolates and in vitro mutants of RIF-resistant M. tuberculosis. 
This research encompassed the following: i) transcriptional profiling of M. tuberculosis with 
different rpoB mutations to determine the effect of these mutations on gene expression; ii) 
exposing RIF mono-resistant isolates to 2 µg/mL of RIF to investigate the effect of this drug 
on gene expression and iii) whole genome sequencing of all in vitro generated mutants used in 
this study to assess whether additional SNPs or in/dels may have influenced gene expression. 
The findings from this study have provided novel insight into understanding the influence of 
different rpoB gene mutations on the transcriptome of M. tuberculosis. 
 
5.1 Deciphering the Impact of rpoB Mutations on Gene Expression 
The growth curves constructed for each of the isolates revealed that WT H37Rv displayed a 
faster growth rate compared to both the H526Y and S531L in vitro mutants generated from 
this strain. Likewise, a similar trend was seen for the drug-sensitive clinical isolate and in 
vitro selected S531L mutant. This finding demonstrates the fitness cost inferred by rpoB 
mutations when the bacterium is not cultured in the presence of RIF (84). When comparing 
the RIF mono-resistant clinical isolates to the in vitro generated mutants, it was apparent that 
the clinical strains grow at a much slower rate. This may be because the laboratory strain of 
M. tuberculosis has adapted to in vitro growth conditions. Alternatively, this may be due to 
the existence of additional mutations in the clinical strains, acquired while in the human host. 
These mutations help the bacterium to adapt and survive in harsh environments; however they 
can lead to an increased fitness cost when grown in a system without cellular stress such as 
the host immune response and antibiotic pressure.  
 
Stellenbosch University  https://scholar.sun.ac.za
66 
 
Comparison of H37Rv gene expression to each of the rpoB mutants revealed that the majority 
of differentially expressed genes, excluding hypothetical proteins, belonged to the 
intermediary metabolism/respiration, and cell wall/cell processes functional categories. In 
both cases, as well as all other functional categories, the majority of the genes involved were 
downregulated in the mutant strains. This trend was amplified in H531, possibly due to the 
transcriptional regulators which were downregulated in the rpoB531 mutant. Of the 7 
differentially expressed regulators, WhiB7 is the best described in literature and has been 
linked to both redox homeostasis and intrinsic drug resistance (99). WhiB7 expression is 
induced upon exposure to fatty acids and antibiotics, such as erythromycin and tetracycline, 
and plays an important role in regulating gene expression by binding to region 4 of the 
housekeeping σ factor, σA (103, 104). However, it is uncertain whether the global trend of 
downregulation seen in the rpoB531 mutant can be accounted for by the downregulation of a 
single transcriptional regulator, considering that whiB7 was upregulated in the rpoB526 
mutant, which also displayed a vast number of downregulated genes. It is possible that the 
effect of WhiB7 is amplified due to other regulators which were downregulated in the 
rpoB531 mutant, and not in the rpoB526 mutant, however these transcriptional regulators 
have not been studied in detail.  
 
Differential expression of 57 and 92 genes were unique to the H526Y and S531L mutants of 
M. tuberculosis H37Rv, respectively. Based on these findings, we suggest that the position of 
the rpoB mutation has a substantial effect on gene expression. Surprisingly, very few genes 
were differentially expressed in both the rpoB mutants, suggesting that each mutation has a 
distinct effect on the transcriptional properties of RNAp. Five genes were downregulated in 
both mutants: three hypothetical proteins (Rv0789c-Rv0791c), citrate synthase (Rv1131), a 
conserved membrane protein (Rv3453); and three genes were upregulated in the rpoB526 
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mutant and downregulated in the rpoB531 mutant: whiB7, tap and eis. Furthermore, hflx, erm 
and cut2, which also play a role in the WhiB7 regulon, followed the same trend in both in 
vitro generated mutants, albeit at a lower level of expression. These same genes were 
downregulated in the rpoB531 mutants with a clinical genetic background, which lends 
support to the notion that WhiB7 plays a major role in the downregulation of metabolism and 
cellular processes we observe in the rpoB531 mutants.  
 
It is also possible that other factors, not accounted for when evaluating gene expression of 
transcriptional regulators, could be playing a role. If mutated RNAp influences RNAp-ligand 
or RNAp-DNA interactions, this may be the cause of the differences we observe when 
comparing the transcriptomes of different rpoB mutants. Based on factors which interact with 
the β and β’ subunits of RNAp, we aimed to systematically evaluate the origin of the 
downregulation of metabolic pathways observed in the rpoB mutants, especially those with a 
S531L mutation. Firstly, as p/ppGpp and CarD directly bind to RNAp in order to mediate the 
stringent response in M. tuberculosis, we evaluated whether an rpoB mutation may influence 
this interaction (Appendix G). Secondly, it is possible that rpoB mutations influence the 
affinity of RNAp for alternate σ factors, which may drive a particular transcriptional response 
(Appendix H). However, after closer investigation, we can conclude that neither of these 
scenarios appeared to fully explain the expression profiles of the rpoB mutants in this study. 
At this stage, an appealing speculation is one which includes two scenarios: rpoB531 
mutations lead to the induction of a tapered stringent response as well as differential 
expression of genes which are part of the Whib7 regulon, both of which lead to the global 
change in gene expression we observe in the rpoB mutants. 
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It is also possible that factors beyond our current understanding can account for the link 
between rpoB mutations and mycobacterial gene expression. A primary example includes the 
interaction between RNAp and sRNA. Unfortunately, our knowledge of sRNA in 
mycobacteria is limited, which prevents us from fully understanding this aspect of 
transcriptional regulation. However, a recent study revealed that MTS2823 sRNA plays an 
important role in mediating the repression of genes involved in exponential growth in M. 
tuberculosis (47). MTS2823 was overexpressed to investigate its role in stationary phase, 
which lead to widespread downregulation of a vast number of genes, primarily those involved 
in energy metabolism and macromolecular synthesis. Although the regulatory mechanism of 
MTS2823 sRNA remains unclear, it is thought that it is comparable to 6S RNA in E. coli, 
which binds directly to RNAp (44, 45). It is possible that a sRNA-RNAp interaction such as 
this is influenced by the presence of an rpoB mutation, which may cause differential 
expression of genes under the control of regulatory sRNA. To further support this theory, a 
study by Windbichler et al observed a number of sRNAs that bind to the β subunit of RNAp 
in E. coli (49). 
 
Alternatively, RNAp processes such as transcription elongation and termination could also be 
affected by the presence of an rpoB mutation. A study in E. coli has revealed that a H526Y 
mutation in rpoB decreases transcription termination at the tryptophan operon attenuator 
(105). As the termination efficiency was not reduced at operons which do not form transcript 
termination structures, the authors suggested that particular rpoB mutations lead to reduced 
efficiency of termination only when mutated RNAp encounters these structures. If the β 
subunit does indeed play an active role in the recognition of termination signals, this could 
indirectly affect the level of gene expression of certain operons when particular rpoB 
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mutations are present. Further studies are needed to investigate these findings in M. 
tuberculosis. 
 
As mutations at codon 531 and 526 of rpoB lead to altered gene expression in M. tuberculosis 
H37Rv, we aimed to confirm whether the same trend is observed when comparing strains 
with different genetic backgrounds. In contrast to the H37Rv mutant set, a greater number of 
genes were differentially expressed when comparing the rpoB mutants with a clinical genetic 
background. Similar to our findings from evaluating the growth curves in this study, this is 
thought to be due to the genetic variations in clinical strains of M. tuberculosis which have 
had the opportunity to adapt in the human host.  
 
When grouping differentially expressed genes according to functional categories, the majority 
were found to be in the intermediary metabolism/respiration, and cell wall/cell processes 
categories, comparable to our findings in the progenitor-mutant analysis. In 9 of the 10 
functional categories, a larger number of genes were differentially expressed in mutant sets 
with a clinical genetic background compared to the H37Rv mutant set, which emphasizes the 
difference between strains with a clinical background and laboratory strains such as H37Rv. 
This is a reminder that research based on the use of reference strains may not be a true 
representation of M. tuberculosis isolated from the host, despite the array of advantages that 
working with such strains have to offer. 
 
Two operons were identified in the 28 genes which were commonly differentially expressed 
when comparing all three mutant sets. The operon comprising of ilvC, ilvN and ilvB1 
displayed downregulation in the S531L mutants, while zwf1 and gnd2 exhibited upregulation.  
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The ilvC gene encodes for ketol-acid reductoisomerase, while ilvN and ilvB1encode for the 
small and large subunits of acetolactate synthase, respectively. Acetolactate synthase 
catalyses the first step of the branched-chain amino acid biosynthesis pathway. A ΔilvB1 
deletion mutant of M. tuberculosis exhibits auxotrophy of all three branched-chain amino 
acids, namely valine, leucine and isoleucine (106). Furthermore, the mutant strain displays 
diminished growth in vitro and attenuated virulence in vivo. Downregulation of these genes in 
the rpoB531 mutants could be an indication of decreased branched-chain amino acid 
biosynthesis. This supports our hypothesis that the full stringent response is not triggered in 
rpoB531 mutants, as increased amino acid biosynthesis is expected once the stringent 
response is initiated.  
 
Zwf1 and Gnd2 are enzymes which play a role in the pentose phosphate pathway and are 
responsible for the production of NADPH. Deletion of the gene which encodes Gnd1 has 
been shown to lead to increased sensitivity to oxidants in Saccharomyces cerevisiae, therefore 
it is considered that a sufficient production of NADPH is necessary to protect cells from 
oxidative stress (107, 108). Furthermore, mutations in zwf1 and gnd2 are associated with 
decreased tolerance of S. cerevisiae to furfural, whereas overexpression of zwf1 allows the 
microorganism to grow in toxic concentrations of this inhibitor, emphasizing the vital role of 
NADPH in stress tolerance (109). We hypothesize that differential expression of these genes 
in the rpoB mutants may influence the redox balance within the cell. Furthermore, a reductive 
shift such as this could contribute to the change in whiB7 expression which was observed, as 
Whib7 has been shown to play a role in redox homeostasis (99). 
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5.2 Transcriptomic Response of rpoB Mutants to Rifampicin Exposure  
A recent study by Louw et al indicated that exposing RIF mono-resistant strains to the critical 
concentration of RIF was able to induce tolerance to ofloxacin (OFL) (6). Strains with the 
rpoB526 mutation pre-exposed to RIF showed an increase in the MIC of OFL after 7 days and 
strains with the rpoB531 mutation showed induction of OFL tolerance after only 24 hours. 
This was thought to be linked to the activation of efflux pumps, as the addition of efflux pump 
inhibitors restored OFL susceptibility in MDR strains of M. tuberculosis. If rpoB531 
mutations are able to condition the bacterium to become tolerant to OFL, this could explain 
why these mutations are more prevalent in RIF resistant clinical strains. To investigate this 
hypothesis, we exposed RIF mono-resistant clinical isolates and in vitro generated mutants 
with different rpoB mutations to the critical concentration of RIF for 24 hours. Surprisingly, 
no significant differential expression was observed when comparing the gene expression 
profiles of RIF exposed and unexposed samples. This remained true for strains with the 
rpoB531 and rpoB526 mutations, indicating that the presence or position of rpoB mutations 
does not influence the transcriptional response of M. tuberculosis to the critical concentration 
of RIF used in this experiment. 
 
Other studies have demonstrated the effect of RIF on gene expression in M. tuberculosis, 
however much higher concentrations of the drug were used in all of these instances, usually 
correlating to the MICs for the individual strains. As previous studies have shown that blood 
serum concentrations of RIF can be as high as 8 - 24 μg/mL, we suggest that higher 
concentrations of RIF be tested to examine the influence of a clinically relevant concentration 
of RIF on gene expression in M. tuberculosis (110, 111). 
 
Stellenbosch University  https://scholar.sun.ac.za
72 
 
5.3 Whole Genome Sequencing of In Vitro Generated Mutants  
Bioinformatic analysis of whole genome sequence data for the rpoB526 mutant generated 
from H37Rv revealed a non-synonymous SNP in a gene which encodes an esterase, lipM. 
LipM is one of 21 annotated proteins in the Lip family of enzymes in M. tuberculosis which 
are thought to play a role in the hydrolysis of host lipids to store trialglycerol as an energy 
source for the cell (8, 112). Transcriptomic data revealed that the SNP did not influence 
expression of this gene, however the SIFT program predicted that the SNP would have an 
effect on protein function. Unfortunately, an accurate structural model could not be generated 
for this protein, therefore further investigation of the polymorphism proved difficult.  
 
In silico modelling of trmB to visualize the SNP identified in the rpoB531 mutant generated 
from H37Rv, revealed that the tyrosine to aspartic acid amino acid change at codon 109 is on 
the surface of the protein. Although the polymorphism does not appear to alter the structure of 
the protein, SIFT predicted that it would have an impact on protein function. According to 
information on TBDB, 4 different polymorphisms have been described in this gene; however 
this particular SNP has not been reported. The trmB gene codes for a tRNA-methyltransferase 
which is essential for mycobacterial growth (113). The function of this enzyme is to catalyse 
the N
7
-methylguanine modification at position 46 in the variable loop of tRNA during tRNA 
maturation. Expression of this gene was slightly lower (0.79 fold) in the rpoB531 mutant of 
H37Rv compared to the rpoB526 mutant and no differential expression was seen when 
comparing the in vitro mutant set without this SNP. This suggests that the polymorphism may 
modify gene expression or enzyme activity. A study by Fu and colleagues demonstrated 
induction of trmB after exposure to 5μg/mL isoniazid and 10μg/mL ethionamide (114). 
Although the authors did not speculate about the reason for this, further investigation may 
reveal a link between trmB and drug resistance in M. tuberculosis. 
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At this stage, we are not able to establish the significance of the synonymous polymorphism 
identified in Rv2185c (TB16.3) in the rpoB531 mutant generated from the drug-sensitive 
clinical isolate. Previously, the identification of synonymous SNPs was disregarded as it was 
assumed that their effect on protein function was inconsequential. Over the past decade, 
however, research based on the Human Genome Project has revealed that these 
polymorphisms occur at a higher frequency than previously thought and that they can, in fact, 
have an impact on the structure and function of proteins (115). Synonymous SNPs, also 
referred to as silent polymorphisms, have since been linked to alterations in mRNA structure 
and stability, as well as protein translation and folding. In a study which investigated 
ethambutol resistance in M. tuberculosis, a synonymous SNP in aftA was found to increase 
the expression of a downstream gene, embC, thereby increasing the level of ethambutol 
resistance in laboratory strains (116). This is an indication that silent polymorphisms are also 
able to influence gene expression of surrounding genes. Unfortunately, Rv2185c does not 
appear to be a part of an operon and gene expression of this gene did not differ between the 
mutant and progenitor strains. Rv2185c encodes for a hypothetical protein to which a function 
or cellular pathway has not been assigned; therefore further investigation of this SNP will first 
require elucidation of the gene product as well as its role in mycobacterial physiology.    
  







Limitations and Future Studies 
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Interestingly, the growth curves for the in vitro mutants generated from H37Rv do not appear 
to correlate to the degree of metabolic downregulation in these strains. The rpoB526 mutant 
displayed the slowest growth rate when compared to H37Rv, whereas the rpoB531 mutant 
exhibited the highest number of downregulated pathways. This is an indication that 
investigating only the transcriptome in these mutants is insufficient when considering the 
impact of rpoB mutations on the physiology of M. tuberculosis. Comprehensive studies, 
which consider the entire process from gene expression to functional gene product, are 
necessary to gain a better perspective of the effects of mutations on the physiology of           
M. tuberculosis. Furthermore, M. tuberculosis which has acquired rpoB mutations in vitro 
may not be the ideal model for strains which have acquired RIF-resistance while in the host. 
Ideally, isolates used in future studies would include a progenitor and rpoB mutant from the 
same patient, obtained before and after acquiring RIF-resistance in vivo. 
 
A study by Gagneux et al. revealed that the fitness cost of rpoB mutations was higher in 
laboratory-derived H526Y mutants than in S531L mutants, regardless of the strain 
background (84). In our study, H37Rv and the two in vitro mutants generated from this 
progenitor, as well as the two RIF-resistant clinical isolates appear to correspond with this 
finding. Interestingly, however, one of the three rpoB526 mutants exhibited a similar growth 
rate to its progenitor for the majority of the exponential phase. To further investigate these 
results, a competition assay could be done to determine the fitness cost in each of the strains 
used in this study. 
 
Expression data for the drug-sensitive clinical isolate varied considerably from the in vitro 
mutants generated from this strain, and the same trend was not seen in the progenitor-mutant 
comparisons for H37Rv, therefore this dataset was excluded from subsequent analyses. As a 
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result, findings from the H37Rv-mutant comparison could not be confirmed in a second strain 
of M. tuberculosis. The differences that were observed could be due to additional mutations or 
in/dels acquired by the in vitro mutants during the Luria–Delbrück fluctuation assay. 
However, gene expression between the two in vitro mutants proved to be relatively similar 
and it is unlikely that the same mutational event occurred in both these samples. Furthermore, 
whole genome sequencing of the strains confirmed that no in/dels or non-synonymous SNPS 
were present when compared to the progenitor strain. Alternatively, it is possible that these 
transcriptional differences arose due to unknown technical problems during culture, RNA 
isolation or microarray sample preparation steps. 
 
To investigate the influence of rpoB mutations on RNAp interactions, the affinity of WT and 
mutated RNAp for p/ppGpp and different σ factors can be evaluated as this will influence 
how M. tuberculosis adapts to external stress and internal stimuli. If RNAp with particular 
rpoB mutations favour binding of certain σ factors or have an increased sensitivity towards 
p/ppGpp, it could explain why these mutations lead to global changes in gene expression. 
Likewise, the relationship of WT and mutated RNAp to RNAp-binding sRNA could be 
investigated to determine whether there is a link between rpoB mutations and this aspect of 
transcriptional regulation. 
 
As the WhiB7 regulon appeared to play a major role in driving differential expression in the 
rpoB mutants studied here, it would be worthwhile to investigate this further. Determining 
whether comparable differential expression of whiB7 can be seen in other clinical isolates of 
RIF resistant M. tuberculosis would confirm the findings from this study. Future studies could 
include transcription profiling of isolates from different strain lineages of M. tuberculosis 
which appear to be driving the MDR-TB epidemic in South Africa, for example Latin 
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American-Mediterranean (LAM) and Low Copy Clade (LCC) lineages (117). Additionally, 
rpoB526 mutants in this study demonstrated upregulation of the eis gene; therefore we are 
interested to determine whether strains with this mutation would have decreased susceptibility 
to kanamycin as this would have an impact on the current second-line treatment regimen. 
 
Recent studies have shown that synonymous polymorphisms should not be overlooked, 
therefore determining the role of the synonymous SNP we identified in TB16.3 would add to 
the findings in this study. However, as little is known concerning the hypothetical protein for 
which this gene encodes, investigating the effect of this SNP on mycobacterial physiology is 
challenging at this stage. Furthermore, different non-synonymous SNPs were found in the in 
vitro generated rpoB mutants, therefore we are not able to hypothesise whether either one of 
the polymorphisms play a role in a compensatory mechanism or drug resistance. Future 
studies should aim to determine whether the polymorphisms identified in this study are 
present in other RIF-resistant samples and the impact they have on mycobacterial physiology. 
 
Lastly, as it is uncertain how the SNPs identified in this study may have influenced the 
transcriptome, differential gene expression observed when comparing progenitor and RIF-
resistant mutants cannot be solely accounted for by the respective rpoB mutations. 
Additionally, regions absent from the H37Rv reference genome and repetitive elements such 
as PE/PPE genes were excluded from the whole genome sequencing analysis; therefore 
variants in these regions may have been overlooked. Although this hampers our aim to link 
rpoB mutations and the phenotype of M. tuberculosis, it is worthwhile to note that before the 
introduction of next generation sequencing technologies, researchers studied the effects of 
mutations unaware that additional polymorphisms could be playing a role. Since the dawn of 
the “omics” era, we will undoubtedly see more studies incorporating this aspect of validation. 
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Investigating the transcriptome of RIF-resistant M. tuberculosis with different rpoB mutations 
has led to an unexpected finding. Strains with rpoB S531L and H526Y mutations exhibit 
downregulation of multiple metabolic and cellular pathways, which appears to be reminiscent 
of the transition from replicating to dormant populations of M. tuberculosis. This effect is 
amplified in S531L mutants, irrespective of the strain’s genetic background. It is known that 
certain resistance-conferring mutations lead to a lower fitness cost in M. tuberculosis; 
however it may also be possible that certain RIF-resistance conferring mutations predispose 
the bacterium to the effect of cellular stress. Findings from this study suggest that rpoB S531L 
mutations could be advantageous to the bacterium in the event of cellular stress, as it is 
possible that bacilli which exhibit downregulation of numerous cellular pathways will be able 
to adapt more rapidly to the array of stress factors within the host.  However, the mechanism 
through which these transcriptional changes are brought about remains unclear. 
 
It is likely that the effects of rpoB mutation are multifactorial, involving altered RNAp 
interactions with termination signals, p/ppGpp, σ factors or transcriptional regulators such as 
Whib7. This indicates that although RIF resistance is a simple process, the aftermath of 
mutations which confer resistance are more complex than previously thought. It is also 
possible that differential expression of the Whib7 regulon leads to a plethora of downstream 
events which would account for the global downregulation we observe in the rpoB S531L 
mutants. Alternatively, there may be aspects of WhiB7 regulation that are currently unknown, 
which could involve transcriptional regulation of a number of different cellular pathways. 
Further elucidation of the role of WhiB7 in rpoB mutants will rely on findings from future 
studies. 
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In this study, results indicate that exposing RIF mono-resistant isolates to the critical 
concentration of RIF (2 μg/mL) is not sufficient to induce a transcriptional response. 
Therefore, we were unable to determine whether treatment with a drug to which the bacterium 
is already resistant would confer an advantage, for example activation of efflux pumps which 
would decrease the intracellular concentration of other anti-TB drugs.  
 
Synonymous and non-synonymous SNPs that are currently unrelated to RIF-resistance were 
identified in 3 of the 4 in vitro mutants used in this study. This suggests that the mycobacterial 
genome is constantly evolving, perhaps not as slowly as previously thought. It is thought that 
the acquisition of polymorphisms is somewhat rare and isolated; however results from this 
study indicate that additional mutation events are taking place concurrently to those which 
confer drug resistance. As the in vitro mutants used in this study were generated using the 
Luria–Delbrück fluctuation assay, it can be assumed that mutational pressure would be even 
greater when the bacterium is in the human host, which would increase the likelihood of 
polymorphisms incorporated in the mycobacterial genome. Further studies will elucidate 
whether these seemingly unrelated polymorphisms play a role in the success of                     
M. tuberculosis as a pathogen. 
 
In conclusion, results from this study indicate that both the position of the rpoB mutation as 
well as the genetic background of the strain plays an important role in the gene expression 
profile of rpoB mutants. The combination of different drug resistance-conferring mutations 
and strain background may result in each strain of M. tuberculosis having unique 
characteristics, demanding ever-more sophisticated approaches to understanding the complex 
physiology of this Machiavellian pathogen. 
 














Preparation of growth media, reagents and buffers 
 
CULTURE MEDIA: 
 Middlebrook 7H9 Broth 
4.7 g Middlebrook 7H9 
900 mL ddH2O 
2 mL glycerol 
500 μL Tween 80 
Autoclave 
Add 100 mL ADC 
Filter Sterilize and store at 4°C 
 
 Middlebrook 7H10 Agar 
19 g Middlebrook 7H10 
900 mL ddH2O 
5 mL glycerol 
Autoclave 
Add 100 mL OADC 
Pour into petri dishes and store at 4°C 
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 Albumin-Dextrose-Catalase (ADC) 
25 g bovine serum albumin 
10 g glucose 
0.75 mL catalase 
Add ddH2O to a final volume of 500 mL 
Filter-sterilize and prepare 50 mL aliquots  
Store at 4°C 
 
DRUG PREPARATION: 
 4000 µg/mL Rifampicin (light-sensitive) 
Dissolve 40 mg of RIF in 1 mL DMSO 
Add sterile water to a final volume of 10 mL  
Prepare 500 µL aliquots in aluminium foil-wrapped tubes 
Store at -80°C 
 
GEL ELECTROPHORESIS: 
 10x TBE Buffer (pH 8.3)  
108 g 0.45 M Tris 
55g 0.44 M boric acid  
7.4g 10 mM EDTA  
Add ddH2O to a final volume of 1 L 
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 1.5% Agarose Gel  
1.5 g agarose  
1.5 μL ethidium bromide  
100 mL 1x TBE buffer 
 
 Loading Dye 
0.25 % xylene cyanol 
50 % glycerol 
 
MICROARRAY HYBRIDIZATION: 
 Phosphate Buffer (pH 8.5-8.7) 
9.5 mL 1 M K2HPO4  
0.5 mL 1 M KH2PO4 
 
 Phosphate Wash Buffer 
0.5 mL 1 M KPO4 (pH 8.5) 
15.25 mL MilliQ water 
84.25 mL 95% ethanol 
 
 Phosphate Elution Buffer 
Dilute 1M KPO4 (pH 8.5) to 4 mM with water 
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 Aminoallyl-dNTP mix 
5 µL 100 mM dGTP 
5 µL 100 mM dCTP 
5 µL 100 mM dATP 
3 µL 100 mM dTTP 
4 µL 100 mM aminoallyl-dUTP 
Add MilliQ water to a final volume of 40 µL 
Store at -20ºC  
 
 Sodium Carbonate Buffer (pH 9.0) 
10.8 g Na2CO3  
80 mL MilliQ water 
Adjust pH to 9.0 with 12 M HCl 
Add MilliQ water to a final volume of 100 mL to give a 1 M solution 
Prepare a 0.1 M solution by diluting 1:10 with water 
 
 Cy-3 and Cy-5 dyes (light-sensitive) 
Resuspend each tube of dried product in 73 µL DMSO 
Wrap tubes in aluminium foil 
Store aliquots at -80ºC 
 
  




 75% Ethanol 
150 mL absolute ethanol 
50 mL DEPC-treated water 
Refrigerate at -20°C for use during RNA isolation 
 
 Extraction Buffer 
5 % sodium glutamate 
50 mM Tris-HCl (pH 7.4) 
25 mM EDTA 
 
 Proteinase K Buffer 
5 % sodium dodecyl sulphate 
100 nM Tris-HCl (pH 7.8) 
50 mM EDTA 
 
 TE Buffer 









Culturing of M. tuberculosis and the initial steps of RNA isolation was done in a BSL-3 
laboratory. The following procedures are considered good laboratory practice with regard to 
the methods used in this study. 
 
 BIO-SAFETY CABINETS 
Before using the biosafety cabinet (BSC), all surfaces and equipment are disinfected with 10 
% Incidin Plus (Antrix Hygiene Ltd, India) and 70 % ethanol. An autoclavable bottle 
containing 10 % Incidin Plus is used to discard cultures to give a final concentration of no less 
than 2 %. Pipette tips, inoculating loops, L-shaped spreaders, cuvettes and Eppendorf tubes 
are rinsed in 10 % Incidin Plus before discarding into a disposable screw-top container. All 
waste generated within the BSC is placed in an autoclave bag and sealed with autoclave tape. 
Before removing the autoclave bag, autoclavable container or any other item from the BSC, it 
is first disinfected with 10 % Incidin Plus and 70 % ethanol. Upon completing work in the 
BSC, all surfaces and equipment are cleaned as before. Aluminium centrifuge buckets are 
soaked overnight in a 2% solution of Incidin Plus. 
 
 INCUBATOR  
The temperature controlled warm room is set at 37ºC. Four minimum/maximum 
thermometers are attached to the shelving and daily temperature logs are kept to ensure proper 
functioning. All cultures to be incubated in the warm room are placed in an air-tight 
secondary container. 
 
 WASTE REMOVAL 
All waste, including autoclavable bottles, gowns, masks and overshoes, are autoclaved at 
121°C for 30 minutes before removing from the BL3 laboratory and placing in designated 
waste bins for off-site disposal. 
 
 




To prevent RNA degradation during the RNA isolation and purification steps, the following 
methods were used to maintain an RNase-free environment: 
 Once samples were processed and removed from the BSL-3 laboratory, a designated 
RNase-free workspace; with laminar flow hood, heating block, centrifuge and 
pipettes; was used. 
 RNaseZap (Ambion, Applied Biosystems, CA, USA) and 70% ethanol were used to 
clean all equipment and work surfaces before and after use.  
 Powder-free nitrile gloves were used at all times and were changed frequently to 
prevent RNase contamination. 
 RNase-free pipette tips, Eppendorf tubes and reagents were used and sample tubes 
were kept closed whenever possible. 
 Glassware was treated with 1% SDS, rinsed with DEPC-treated water and oven-baked 
at 100ºC overnight to ensure that it was RNase-free. 
 Water used to clean glassware and prepare 75% ethanol was treated with 0.1% DEPC, 










Concentrations of isolated RNA as determined by the Experion RNA StdSens analysis kit and 
Experion automated electrophoresis station. 
Sample Triplicate number 
Concentration (ng/µL) 
Unexposed RIF Exposed  
C526 1 464.34 530.23 
 2 567.06 592.85 
 3 761.48 517.88 
C531 1 124.36 95.68 
 2 332.69 468.73 
 3 336.35 432.33 
M526 1 692.04 880.87 
 2 477.98 517.07 
 3 253.22 367.37 
M531 1 719.41 633.61 
 2 665.59 614.39 
 3 653.34 850.27 
M0 1 417.53 - 
 2 417.97 - 
 3 512.73 - 
H526 1 371.26 - 
 2 869.19 - 
 3 487.27 - 
H531 1 292.79 - 
 2 426.50 - 
 3 513.83 - 
H37Rv 1 408.21 - 
 2 374.04 - 
 3 586.79 - 
 
  




Cellular pathways influenced by different rpoB mutations. Only pathways with at least 3 
differentially expressed genes are listed here. The number of genes involved in each pathway 
is given in parentheses. 
DOWNREGULATED IN H526 
Pantothenate and CoA biosynthesis (5) 
Glycine, serine and threonine metabolism (4) 
Geraniol degradation (4) 
Aminoacyl-tRNA biosynthesis (4) 
ABC transporters (4) 
β-Alanine metabolism (4) 
Glutathione metabolism (3) 
Cysteine and methionine metabolism (3) 
Purine metabolism (3) 
 
UPREGULATED IN H526 
Butanoate metabolism (3) 
 
DOWNREGULATED IN H531 
Limonene and pinene degradation (15) 
Propanoate metabolism (13) 
Butanoate metabolism (13) 
Geraniol degradation (11) 
Valine, leucine and isoleucine degradation (11) 
Fatty acid metabolism (10) 
Tryptophan metabolism (10) 
Lysine degradation (9) 
Benzoate degradation (9) 
β-Alanine metabolism (9) 
Aminobenzoate degradation (9) 
Caprolactam degradation (7) 
Purine metabolism (7) 
Phenylalanine metabolism (7) 
 
UPREGULATED IN H531 
Histidine metabolism (4) 
Aminoacyl-tRNA biosynthesis (3) 
ABC transporters (3) 
 




DOWNREGULATED IN H531 
Histidine metabolism (7) 
Arginine and proline metabolism (6) 
Polycyclic aromatic hydrocarbon degradation (6) 
Pyruvate metabolism (6) 
Base excision repair (5) 
Two-component system (5) 
Biotin metabolism (5) 
Citrate cycle (5) 
Amino sugar and nucleotide sugar metabolism (4) 
Glyoxylate and dicarboxylate metabolism (4) 
Tyrosine metabolism (4) 
Pantothenate and CoA biosynthesis (4) 
Bisphenol degradation (4) 
Glycolysis/Gluconeogenesis (4) 
Glycerolipid metabolism (3) 
Oxidative phosphorylation (3) 
Nucleotide excision repair (3) 
Ether lipid metabolism (3) 
Sulfur metabolism (3) 
Valine, leucine and isoleucine biosynthesis (3) 
Homologous recombination (3) 
Pentose and glucuronate interconversions (3) 
Ribosome (3) 
ABC transporters (3) 
Toluene degradation (3) 
  




FastQC reports used to assess quality of whole genome sequence data 
 
Figure F1. The distribution of quality scores across all bases. The 
blue line represents the mean quality, the red lines represent median 
values and the green and red regions of the plot indicate high and low 
quality scores, respectively. 
 
 
Figure F2. The distribution of quality across all sequences. Score 
used to assess whether a proportion of the sequences have universally 
low quality scores. 







Figure F3. Sequence content across all bases. As M. tuberculosis has a 
GC-rich genome, the percentage GC content is expected to be >60%. 
 
 
Figure F4. Level of sequence duplication. A high level of duplication 
could suggest an enrichment bias such as PCR over-amplification. 
  




Do rpoB Mutations Induce a Stringent Response? 
One of the most important interactions RNAp undergoes to fulfil its enzymatic function is 
during transcription initiation, when the holoenzyme recognizes and binds to certain 
sequences within the promoter region. In E. coli, it has been found that particular rpoB 
mutations (S531F, D532A, L533P, T563P) lead to downregulation of the rpoD operon, which 
is negatively regulated by the stringent response (118). Likewise, induction of genes that are 
positively controlled by the stringent response was observed in these mutants (119, 120). The 
same four RIF-resistance conferring mutations were found to facilitate the growth of 
relA/spoT double-deletion mutants in minimal media, whereas strains without an rpoB 
mutation require supplementation with amino acids. Zhuo and Jin speculated that these 
findings indicate that mutated RNAp mimics WT RNAp during the stringent response. In the 
study which aimed to investigate this hypothesis, the authors concluded that mutated RNAp 
causes unstable initiation complexes at stringent promoters in E. coli (121). As a result, 
transcription of stringent genes is decreased, which allows more RNAp molecules to be 
available for transcription from promoters which are positively regulated by the stringent 
response. 
 
Guanosine nucleotides (p/ppGpp) and the transcriptional regulator, CarD, initiate the stringent 
response in prokaryotes when amino acid availability is low. As ppGpp/pppGpp is able to 
regulate transcription by binding directly to RNAp at a site near the C-terminus of the β 
subunit, it is possible that an rpoB mutation could also influence this interaction. Strains of   
E. coli harbouring an rpoB mutation have been found to be more sensitive to ppGpp/pppGpp 
which would lead to the activation of the stringent response without the necessary increase in 
ppGpp/pppGpp (40). Furthermore, it has been found that CarD is essential for resistance to 
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oxidative stress and that weakening the interaction between CarD and RNAp leads to 
increased sensitivity of M. tuberculosis to RIF (42, 122).  
 
Dahl and colleagues demonstrated that ppGpp/pppGpp regulates the expression of 159 genes 
in M. tuberculosis during starvation (38). Results from this study were highly comparable to a 
study by Betts et al, which investigated the transcriptomic response of M. tuberculosis to 
nutrient starvation (21). This verifies the role that ppGpp/pppGpp plays in orchestrating the 
stringent response and subsequent shutdown of prokaryotic metabolism. Genes which were 
downregulated after 24 hours of starvation were compared to the present study to determine 
whether a similar trend could be observed, however the same extent of differential expression 
was not seen. Genes which were greatly downregulated in the study by Betts et al were only 
marginally downregulated in the present study. Furthermore, a number of genes which were 
downregulated in the starvation study were upregulated in either of the rpoB mutants studied 
here. This indicates that the complete stringent response is not triggered in rpoB mutants; 
however, it is a possibility that the downregulation of metabolic pathways that we observed in 
this study demonstrates a diminished stringent response. 
 
  




Do rpoB Mutations Induce a Stress Response? 
To determine whether rpoB mutations elicit a constitutive stress response, Bergval and 
colleagues investigated the expression of recA and dnaE2 in six in vitro mutants with 
different rpoB mutations (123). No differential expression of recA was seen, however a 2-5 
fold induction of dnaE2 was seen in 4 of the 6 mutants used in the study. Interestingly, 
rpoB531 and rpoB526 mutants were the two which did not demonstrate upregulation of either 
recA or dnaE2. Expression data from the present study agrees with these findings, therefore 
we can conclude that the rpoB mutations studied here do not facilitate recA and dnaE2-
mediated adaptation in M. tuberculosis. However, it is possible that a stress response is 
initiated by the binding of alternative σ factors to the RNAp core enzyme. 
 
If rpoB mutations lead to a change in the affinity of RNAp for particular σ factors, a 
transcriptional response could be initiated by directing RNAp to different promoters. The 
basis of such a response could be due to an alteration in the interaction between the σ factor 
and β-subunit of RNAp. As different σ factors bind to RNAp to increase the affinity of the 
enzyme for specific promoter regions, we can hypothesize that the presence of an rpoB 
mutation would interfere with the usual behaviour of these two subunits, and may lead to 
increased affinity of alternate σ factors. This would explain the difference in gene expression 
we observe when comparing WT and rpoB mutants of M. tuberculosis.  
 
Numerous studies have been done to investigate which operons are under the control of 
different σ factors found in M. tuberculosis; a review by Sachdeva et al summarizes this 
information comprehensively (124). We aimed to investigate whether the genes which were 
differentially expressed in each of the rpoB mutants studied here could be associated with a 
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particular σ factor. Surprisingly, only a small group of genes that are linked to σA appeared to 
match this criterion, therefore the influence of rpoB mutations on the affinity of RNAp for 
alternative σ factors remains unknown.  
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